Publications

AuthorsTitlePublished DateJournalCitation Link
Wang M, Ge L, Chen L, Komarow L, Hanson B, Reyes J, Cober E, Alenazi T, Zong Z, Xie Q, Liu Z, Li L, Yu Y, Gao H, Kanj SS, Figueroa J, Herc E, Cordova E, Weston G, Tambyah PA, Garcia-Diaz J, Kaye KS, Dhar S, Munita JM, Salata RA, Vilchez S, Stryjewski ME, Villegas Botero MV, Iovleva A, Evans S, Baum K, Hill C, Kreiswirth BN, Patel R, Paterson DL, Arias CA, Bonomo RA, Chambers HF, Fowler VG Jr., Satlin MJ, van Duin D, Doi Y, Mutli-Drug Resistant Organism Network InvestigatorsClinical Impact of Carbapenem-Resistant Acinetobacter baumannii Infection: A Snapshot from an International Cohort29-Sep-23Clin Infect Dis Clin Infect Dis. 2023 Sep 20;ciad556. doi: 10.1093/cid/ciad556
Jezek A, del Rio CAntibacterial Resistance, Research and Funding 202415-Oct-23Clin Infect Dis Clin Infect Dis. 2023;77(Supplement_4):S277-S278. doi:10.1093/cid/ciad473
Chambers HF, Cross HR, Evans SR, Patel R, Fowler Jr. VGThe Antibacterial Resistance Leadership Group: Scientific Advancements and Future Directions15-Oct-23Clin Infect Dis Clin Infect Dis. 2023;77(Supplement_4):S279-S287. doi:10.1093/cid/ciad475
Cross H, Evans SR, Chambers HF, Patel R, Fowler Jr. VGUnder the Hood: The Scientific Leadership, Clinical Operations, Statistical and Data Management, and Laboratory Centers of the Antibacterial Resistance Leadership Group15-Oct-23Clin Infect Dis Clin Infect Dis. 2023;77(Supplement_4):S288-S294. doi:10.1093/cid/ciad529
Doernberg SB, Arias CA, Altman DR, Babiker A, Boucher HW, Creech CB, Cosgrove SE, Evans SR, Fowler VG, Fritz SA, Hamasaki T, Kelly BJ, Leal SM, Liu C, Lodise TP, Miller LG, Munita JM, Murray BE, Pettigrew MM, Ruffin F, Scheetz MH, Shopsin B, Tran TT, Turner NA, Williams DJ, Zaharoff S, Holland TL; Antibacterial Resistance Leadership Group.Priorities and Progress in Gram-Positive Bacterial Infection Research by the Antibacterial Resistance Leadership Group15-Oct-23Clin Infect Dis Clin Infect Dis. 2023;77(Supplement_4):S295-S304. doi:10.1093/cid/ciad565
Satlin MJ, van Duin D, Tamma PD, Lodise TP, Van Tyne D, Rodvold KA, Rouphael N, Bonomo RA, Doi Y, Antibacterial Resistance Leadership GroupPriorities and Progress in Gram-Negative Bacterial Infection Research by the Antibacterial Resistance Leadership Group15-Oct-23Clin Infect Dis Clin Infect Dis. 2023;77(Supplement_4):S305-S313. doi:10.1093/cid/ciad547
Hanson KE, Banerjee R, Doernberg SB, Satlin MJ, Simner PJ, Tillekeratne LG, Patel R for the Antibacterial Resistance Leadership GroupPriorities and Progress in Diagnostic Research by the Antibacterial Resistance Leadership Group15-Oct-23Clin Infect Dis Clin Infect Dis. 2023;77(Supplement_4):S314-S320. doi:10.1093/cid/ciad541
Evans SR, Patel R, Hamasaki T, Howard-Anderson J, Kinamon T, King HA, Collyar D, Cross HR, Chambers HF, Fowler VG, Boucher HW, for the Antibacterial Resistance Leadership GroupThe Future Ain't What It Used to Be…Out With the Old…In With the Better: Antibacterial Resistance Leadership Group Innovations15-Oct-23Clin Infect Dis Clin Infect Dis. 2023;77(Supplement_4):S321-S330. doi:10.1093/cid/ciad538
Harris AD, Souli M, Pettigrew MM, for the Antibacterial Resistance Leadership GroupThe Next Generation: Mentoring and Diversity in the Antibacterial Resistance Leadership Group15-Oct-23Clin Infect Dis Clin Infect Dis. 2023;77(Supplement_4):S331-S335. doi:10.1093/cid/ciad532
Woodworth MH, Conrad RE, Haldopoulos M, Pouch SM, Babiker A, Mehta AK, Wang C, Strudwick A, Friedman-Moraco R, Ziegler TR, Liu KH, Jones DP, Mehta C, Weiss DS, Larsen CP, Konstantinidis KT, Kraft CSRandomized Trial: Fecal Microbiota Transplant Promotes Reduction of Antimicrobial Resistance by Strain Replacement01-Nov-23Sci Transl Med Sci Transl Med. 2023;15(720):eabo2750. doi:10.1126/scitranslmed.abo2750
Hareza DA, Cosgrove SE, Simner PJ, Harris AD, Bergman Y, Conzemius R, Jacobs E, Beisken S, Tamma PD for the Antibacterial Resistance Leadership GroupIs Carbapenem Therapy Necessary for the Treatment of Non-CTX-M ESBL-Producing Enterobacterales Bloodstream Infections?16-Nov-23Clin Infect Dis Clin Infect Dis. 2023 Nov 16:ciad703. doi: 10.1093/cid/ciad703.
Parmar K, Fackler JR, Lee M, Agrawal P, Barreto-Sanz M, Ellison DW, Filippov AA, Nikolich MP, Tamma PD, Souli M, Evans S, Komarow L, Greenwood-Quaintance KE, Cunningham SA, Patel R, for the Antibacterial Resistance Leadership GroupInterlaboratory Comparison of Pseudomonas aeruginosa Phage Susceptibility Testing19-Dec-23J Clin Microbiol J Clin Microbiol. 2023 Dec 19;61(12):e0061423. doi: 10.1128/jcm.00614-23.
Boutzoukas AE, Komarow L, Chen L, Hanson B, Kanj SS, Liu Z, Salcedo Mendoza S,Ordonez K, Wang M, Paterson DL, Evans S, Ge L, Giri A, Hill C, Baum K, Bonomo R, Kreiswirth B, Patel R, Arias CA, Chambers HF, Fowler VG Jr., van Duin D; on behalf of the Antibacterial Resistance Leadership Group and Multi-Drug Resistant Organism Network InvestigatorsInternational epidemiology of carbapenemase-producing Escherichia coli isolates15-Aug-23Clin Infect Dis Clin Infect Dis. 2023 Aug 22;77(4):499-509. doi: 10.1093/cid/ciad288
Kinamon T, Gopinath R, Waack U, Needles M, Rubin D, Collyar D, Doernberg SB, Evans S, Hamasaki T, Holland TL, Howard-Anderson J, Chambers H, Fowler VG Jr., Nambiar S, Kim P, Boucher HWExploration of a Potential DOOR Endpoint for Complicated Intra-Abdominal Infections Using Nine Registrational Trials for Antibacterial Drugs22-Aug-23Clin Infect Dis Clin Infect Dis. 2023 Aug 22;77(4):649-656. doi: 10.1093/cid/ciad239
Rouphael N, Winokur P, Keefer MC, Traenkner J, Drobeniuc A, Doi Y, Munsiff S, Fowler VG, Evans S, Oler RE, Tuyishimire B, Lee M, Ghazaryan V, Chambers HF; for the DMID 15-0045 Study GroupDaily Fosfomycin Use for Complicated Urinary Tract Infections12-Sep-23mBio mBio. 2023 Sep 12;e0167723. doi: 10.1128/mbio.01677-23. Online ahead of print
Cuello L, Alvarez Otero J, Greenwood-Quaintance KE, Hanson B, Chen L, van Duin D, Komarow L, Ge L, Lancaster ZD, Gordy GG, Schuetz AN, Patel RPoor Sensitivity of the MALDI Biotyper(r) MBT Subtyping Module for Detection of Klebsiella pneumoniae Carbapenemase (KPC) in Klebsiella species20-Sep-23Antibiotics Antibiotics. 2023 Sep 20;12(9):1465. doi: 10.3390/antibiotics12091465
Wang M, Ge L, Chen L, Komarow L, Hanson B, Reyes J, Cober E, Alenazi T, Zong Z, Xie Q, Liu Z, Li L, Yu Y, Gao H, Kanj SS, Figueroa J, Herc E, Cordova E, Weston G, Tambyah PA, Garcia-Diaz J, Kaye KS, Dhar S, Munita JM, Salata RA, Vilchez S, Stryjewski ME, Villegas Botero MV, Iovleva A, Evans S, Baum K, Hill C, Kreiswirth BN, Patel R, Paterson DL, Arias CA, Bonomo RA, Chambers HF, Fowler VG Jr., Satlin MJ, van Duin D, Doi Y, Mutli-Drug Resistant Organism Network InvestigatorsClinical Impact of Carbapenem-Resistant Acinetobacter baumannii Infection: A Snapshot from an International Cohort20-Sep-23Clin Infect Dis Clin Infect Dis. 2023 Sep 20;ciad556. doi: 10.1093/cid/ciad556. Online ahead of print
Howard-Anderson J, Hamasaki T, Dai W, Collyar D, Rubin D, Nambiar S, Kinamon T, Leister-Tebbe H, Hill C, Geres H, Holland TL, Doernberg SB, Chambers HF, Fowler Jr. VG, Evans SR, Boucher HWMoving Beyond Mortality: Development and Application of a Desirability of Outcome Ranking (DOOR) Endpoint for Hospital-Acquired Bacterial Pneumonia and Ventilator Associated Bacterial Pneumonia22-Sep-23Clin Infect Dis Clin Infect Dis. 2023 Sep 22;ciad576. doi: 10.1093/cid/ciad576. Online ahead of print
Boutzoukas AE, Komarow L, Chen L, Hanson B, Kanj SS, Liu Z, Salcedo Mendoza S,Ordonez K, Wang M, Paterson DL, Evans S, Ge L, Giri A, Hill C, Baum K, Bonomo R, Kreiswirth B, Patel R, Arias CA, Chambers HF, Fowler VG Jr., van Duin D; on behalf of the Antibacterial Resistance Leadership Group and Multi-Drug Resistant Organism Network InvestigatorsInternational epidemiology of carbapenemase-producing Escherichia coli isolates08-May-23Clin Infect DisClin Infect Dis. 2023;ciad288. doi:10.1093/cid/ciad288
Simner PJ, Dien Bard J, Doern C, Johnson JK, Westblade L, Yenokyan G, Patel R, Hanson KE; for the Antibacterial Resistance Leadership GroupReporting of Antimicrobial Resistance from Blood Cultures, an Antibacterial Resistance Leadership Group Survey Summary: Resistance Marker Reporting Practices from Positive Blood Cultures03-May-23Clin Infect DisClin Infect Dis. 2023;76(9):1550-1558. doi:10.1093/cid/ciac952
Kinamon T, Gopinath R, Waack U, Needles M, Rubin D, Collyar D, Doernberg SB, Evans S, Hamasaki T, Holland TL, Howard-Anderson J, Chambers H, Fowler VG Jr., Nambiar S, Kim P, Boucher HWExploration of a Potential DOOR Endpoint for Complicated Intra-Abdominal Infections Using Nine Registrational Trials for Antibacterial Drugs19-Apr-23Clin Infect DisClin Infect Dis. 2023 Apr 19;ciad239. doi: 10.1093/cid/ciad239. Online ahead of print.
Tsalik EL, Rouphael NG, Sadikot RT, Rodriguez-Barradas MC, McClain MT, Wilkins DM, Woods CW, Swamy GK, Walter EB, El Sahly HM, Keitel WA, Mulligan MJ, Tuyishimire B, Serti E, Hamasaki T, Evans SR, Ghazaryan V, Lee M, Lautenbach E, and the TRAP-LRTI Study Group, on behalf of the Antibacterial Resistance Leadership GroupEfficacy and safety of azithromycin versus placebo to treat lower respiratory tract infections associated with low procalcitonin: a randomised, placebo-controlled, doubleblind, non-inferiority trial01-Apr-23Lancet Infect DisLancet Infect Dis. 2023 Apr;23(4):484-495. doi: 10.1016/S1473-3099(22)00735-6. Epub 2022 Dec 13.
Sivapalan P, Staehr Jensen J-UProcalcitonin to reduce antimicrobial overuse in patients with lower respiratory tract infection: time for re-evaluation of our prescription culture?01-Apr-23Lancet Infect DisLancet Infect Dis. 2023 Apr;23(4):390-391. doi: 10.1016/S1473-3099(22)00757-5. Epub 2022 Dec 13.
Reyes J, Komarow L, Chen L, Ge L, Hanson BM, Cober E, Herc E, Alenazi T, Kaye KS, Garcia-Diaz J, Li L, Kanj SS, Liu Z, Onate JM, Salata RA, Marimuthu K, Gao H, Zong Z, Valderrama-Beltran SL, Yu Y, Tambyah P, Weston G, Salcedo S, Abbo LM, Xie Q, Ordonez K, Want M, Stryjewski M, Munita JM, Paterson DL, Hill C, Baum K, Bonomo RA, Kreiswirth BN, Villegas MV, Patel R, Arias CA, Chambers HF, Fowler VG, Doi Y, van Duin D, Satlin MJ; for the the Prospective Observational POP Study Investigators and the Antibacterial Resistance Leadership GroupGlobal Epidemiology of Carbapenem-resistant Pseudomonas aeruginosa and Associated Carbapenemases (POP): a Prospective Cohort Study2023-03-23Lancet MicrobeLancet Microbe. 2023 Mar;4(3):e159-e170. doi: 10.1016/S2666-5247(22)00329-9. Epub 2023 Feb 9.
Patel R, Tsalik EL, Evans S, Fowler VG Jr., Doernberg SBClinically Adjudicated Reference Standards for Evaluation of Infectious Diseases Diagnostics04-Mar-23Clin Infect DisClin Infect Dis. 2023 Mar 4;76(5):938-943. doi: 10.1093/cid/ciac829.
Reyes J, Komarow L, Chen L, Ge L, Hanson BM, Cober E, Herc E, Alenazi T, Kaye KS, Garcia-Diaz J, Li L, Kanj SS, Liu Z, Onate JM, Salata RA, Marimuthu K, Gao H, Zong Z, Valderrama-Beltran SL, Yu Y, Tambyah P, Weston G, Salcedo S, Abbo LM, Xie Q, Ordonez K, Want M, Stryjewski M, Munita JM, Paterson DL, Hill C, Baum K, Bonomo RA, Kreiswirth BN, Villegas MV, Patel R, Arias CA, Chambers HF, Fowler VG, Doi Y, van Duin D, Satlin MJ; for the the Prospective Observational POP Study Investigators and the Antibacterial Resistance Leadership GroupGlobal Epidemiology of Carbapenem-resistant Pseudomonas aeruginosa and Associated Carbapenemases (POP): a Prospective Cohort Study01-Mar-23Lancet MicrobeLancet Microbe. 2023 Mar;4(3):e159-e170. doi: 10.1016/S2666-5247(22)00329-9. Epub 2023 Feb 9.
Howard-Anderson J, Hamasaki T, Dai W, Collyar D, Rubin D, Nambiar S, Kinamon T, Hill C, Holland TL, Doernberg SB, Chambers HF, Fowler VG Jr., Evans SR, Boucher HW; on behalf of the Antibacterial Resistance Leadership GroupImproving Traditional Registrational Trial Endpoints: Development and Application of a Desirability of Outcome Ranking (DOOR) Endpoint for Complicated Urinary Tract Infection Clinical Trials08-Feb-23Clin Infect Dis
Clin Infect Dis. 2023 Feb 8;76(3):e1157-e1165. doi: 10.1093/cid/ciac692.
Anesi JA, Lautenbach E, Thom KA, Tamma PD, Blumberg EA, Alby K, Mitchell SL, Bilker WB, Werzen A, Ammazzalorso A, Tolomeo P, Omorogbe J, Pineles L, Han JHClinical Outcomes and Risk Factors for Carbapenem-resistant Enterobacterales Bloodstream Infection in Solid Organ Transplant Recipients01-Jan-23TransplantationTransplantation. 2023 Jan 1;107(1):254-263.
Tamma PD, Souli M, Billiard M, Campbell J, Conrad D, Ellison DW, Evans B, Evans SR, Greenwood-Quaintance KE, Filippov AA, Geres HS, Hamasaki T, Hopkins RJ, Komarow L, Nikolich MP, Lodise TP, Nayak SU, Norice-Tra C, patel R, Pride D, Russell J, Van Tyne D, Chambers HF, Fowler VG Jr., Schooley RTSafety and Microbiological Activity of Phage Therapy in Persons with Cystic Fibrosis Colonized with Pseudomonas aeruginosa: Study Protocol for a Phase 1b/2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial2022-12-28TrialsTrials. 2022 Dec 28;23(1):1057. doi: 10.1186/s13063-022-07047-5.
Lodise TP, O'Donnell JN, Balevic S, Liu X, Gu K, George J, Ghazaryan V, Beresnev T, Raja S, Guptill JT, Saharoff S, Schwager N, Fowler VG Jr., Wall A, Wiegand K, Chambers HF, Antibacterial Leadership Resistance GroupPharmacokinetics of Ceftazidime-Avibactam in Combination with Aztreonam (COMBINE) in a Phase 1 Open, Labeled Study of Healthy Adults20-Dec-22Antimicrob Agents ChemotherAntimicrob Agents Chemother. 2022;66(12):e0093622. doi:10.1128/aac.00936-22
Lodise TP, O'Donnell N, Raja S, Guptill JT, Zaharoff S, Schwager N, Fowler VG Jr., Ghazaryan V, Beresnev T, Knisely JM, Norice-Tra CT, Wall A, Wiegand K, Serti Chrisos E, Balevic S, Chambers HF, Antibacterial Resistance Leadership GroupSafety of Ceftazidime-Avibactam in Combination with Aztreonam (COMBINE) in a Phase I, Open-Label Study in Healthy Adult Volunteers20-Dec-22Antimicrob Agents ChemotherAntimicrob Agents Chemother. 2022 Dec 20;66(12):e0093522.
Sivapalan P, Staehr Jensen J-UProcalcitonin to reduce antimicrobial overuse in patients with lower respiratory tract infection: time for re-evaluation of our prescription culture?2022-12-13Lancet Infect DisLancet Infect Dis. 2022 Dec 13;S1473-3099(22)00757-5. doi: 10.1016/S1473-3099(22)00757-5.
Tsalik EL, Rouphael NG, Sadikot RT, Rodriguez-Barradas MC, McClain MT, Wilkins DM, Woods CW, Swamy GK, Walter EB, El Sahly HM, Keitel WA, Mulligan MJ, Tuyishimire B, Serti E, Hamasaki T, Evans SR, Ghazaryan V, Lee M, Lautenbach E, and the TRAP-LRTI Study Group, on behalf of the Antibacterial Resistance Leadership GroupEfficacy and safety of azithromycin versus placebo to treat lower respiratory tract infections associated with low procalcitonin: a randomised, placebo-controlled, doubleblind, non-inferiority trial2022-12-13Lancet Infect DisLancet Infect Dis. 2022 Dec 13;S1473-3099(22)00735-6. doi: 10.1016/S1473-3099(22)00735-6.
Lopez SStudy Evaluates Biomarker to Help Curb Unnecessary Antibiotic Use: Placebo Worse Than Antibiotics After 5 Days, But Similar at Day 112022-12-13DukeHealthhttps://corporate.dukehealth.org/news/study-evaluates-biomarker-help-curb-unnecessary-antibiotic-use
Chastre J, Francois B, Bourgeois M, Komnos A, Ferrer R, Rahav G, De Schryver N, Lepape A, Koksal I, Luyt C-E, Sanchez Garcia M, Torres A, Eggimann P, Koulenti D, Holland TL, Ali O, Shoemaker K, Ren P, Sauser J, Ruzin A, Tabor DE, Akhgar A, Wu Y, Jiang Y, DiGiandomenico A, Colbert S, Vandamme D, Coenjaerts F, Malhotra-Kumar S, Timbermont L, Oliver A, Barraud O, Bellamy T, Bonten M, Goossens H, Reisner C, Esser MT, Jafri HS; COMBACTE-MAGNET EVADE Study GroupSafety, efficacy, and pharmacokinetics of gremubamab (MEDI3902), an anti-Pseudomonas aeruginosa bispecific human monoclonal antibody, in P. aeruginosa-colonised, mechanically ventilated intensive care unit patients: a randomised controlled trial2022-11-15Crit CareCrit Care. 2022 Nov 15;26(1):355. doi: 10.1186/s13054-022-04204-9.
Patel R, Tsalik EL, Evans S, Fowler VG Jr., Doernberg SBClinically Adjudicated Reference Standards for Evaluation of Infectious Diseases Diagnostics2022-10-20Clin Infect DisClin Infect Dis. 2022 Oct 20;ciac829. doi: 10.1093/cid/ciac829. Online ahead of print.
Shrestha R, Luterbach CL, Dai W, Komarow L, Earley M, Weston G, Herc E, Jacob JT, Salata R, Wong D, Anderson D, Rydell KB, Arias CA, Chen L, van Duin D, for the MDRO InvestigatorsCharacteristics of Community-acquired Carbapenem Resistant Enterobacterales2022-09-30J Antimicrob ChemotherJ Antimicrob Chemother. 2022 Sep 30;77(10):2763-2771. doi: 10.1093/jac/dkac239.
Kwon J, Kong Y, Wade M, Williams DJ, Creech CB, Evans S, Walter EB, Martin JM, Gerber JS, Newland JG, Hofto ME, Staat MA, Fowler VG, Chambers HF, Huskins WC, Pettigrew MM; on behalf of the Antibacterial Resistance Leadership GroupGastrointestinal Microbiome Disruption and Antibiotic-Associated Diarrhea in Children Receiving Antibiotic Therapy for Community-Acquired Pneumonia2022-09-21J Infect DisJ Infect Dis. 2022 Sep 21;226(6):1109-1119. doi: 10.1093/infdis/jiac082.
Hansen MA, Valentine-King M, Zoorob R, Schlueter M, Matas JL, Willis SE, Danek LCK, Muldrew K, Zare M, Hudson F, Atmar RL, Chou A, Trautner B, Grigoryan LPrevalence and predictors of urine culture contamination in primary care: A cross-sectional study2022-09-19Int J Nurs StudInt J Nurs Stud. 2022 Oct;134:104325. doi: 10.1016/j.ijnurstu.2022.104325. Epub 2022 Jul 11.
Mumma JM, Howard-Anderson J, Morgan J, Schink K, Wheatley MJ, Kraft C, Lane M, Kaufman N, Ayeni O, Brownsword EA, Jacob JTHealthcare Worker Mental Models of Patient Care Tasks in the Context of Infection Prevention and Control2022-09-02Infect Control Hosp EpidemiolInfect Control Hosp Epidemiol. 2022 Sep;43(9):1123-1128. doi: 10.1017/ice.2021.368. Epub 2021 Sep 10.
Jiang J, Chen X, Xu X, Fowler VG Jr., van Duin D, Wang MCarbapenemase-Encoding Gene Copy Number Estimator (CCNE): a Tool for Carbapenemase Gene Copy Number Estimation2022-08-31Microbiol SpectrMicrobiol Spectr. 2022 Aug 31;10(4):e010002. doi: 10.1128/spectrum.01000-22. Epub 2022 Jul 5.
Howard-Anderson J, Hamasaki T, Dai W, Collyar D, Rubin D, Nambiar S, Kinamon T, Hill C, Holland TL, Doernberg SB, Chambers HF, Fowler VG Jr., Evans SR, Boucher HW; on behalf of the Antibacterial Resistance Leadership GroupImproving Traditional Registrational Trial Endpoints: Development and Application of a Desirability of Outcome Ranking (DOOR) Endpoint for Complicated Urinary Tract Infection Clinical Trials2022-08-29Clin Infect DisClin Infect Dis. 2022 Aug 29;ciac692. doi: 10.1093/cid/ciac692. Online ahead of print.
Moore K, Lautenbach E, Blumberg EA, Han J, Heun Lee D, Clauss H, Hasz R, Bilker WB, Molnar E, Alimenti D, West S, Tolomeo P, Anesi JAImpact of deceased organ donor injection drug use on donor culture positivity and recipient outcomes2022-08-19Transpl Infect DisTranspl Infect Dis. 2022 Aug 19;e13942. doi: 10.1111/tid.13942. Online ahead of print.
Anesi JA, Lautenbach E, Thom KA, Tamma PD, Blumberg EA, Alby K, Bilker WB, Werzen A, Ammazzalorso A, Tolomeo P. Omorogbe J, Pineles L, Han JHClinical Outcomes and Risk Factors for Carbapenem-resistant Enterobacterales Bloodstream Infection in Solid Organ Transplant Recipients2022-07-19TransplantationTransplantation. 2022 Jul 19. doi: 10.1097/TP.0000000000004265. Online ahead of print.
Turner NA, Zaharoff S, King H, Evans S, Hamasaki T, Lodise T, Riccobene T, Patel R, Doernberg SB, Ghazaryan V, Beresnev T, Fowler VG Jr, Holland TL; on behalf of the Antibacterial Resistance Leadership GroupDalbavancin as an Option for Treatment of S. aureus Bacteremia (DOTS): Study Protocol for a Phase 2b, Multicenter, Randomized, Open-label Clinical Trial2022-05-16TrialsTrials. 2022 May 16;23(1):407. doi: 10.1186/s13063-022-06370-1.
Nordstrom HR, Evans DR, Finney AG, Westbrook KJ, Zamora PF, Iovleva A, Yassin MH, Bomberger JM, Shields RK, Doi Y, Van Tyne DGenomic and functional characterization of Pseudomonas aeruginosa-targeting bacteriophages isolated from hospital wastewater2022-05-10iScienceiScience. 2022 May 10;25(6):104372. doi: 10.1016/j.isci.2022.104372. eCollection 2022 Jun 17.
Jacobs JL, Bain W, Naqvi A, Staines B, Castanha PMS, Yang H, Boltz VF, Barratt-Boyes S, Marques ETA, Mitchell SL, Methe B, Olonisakin TF, Haidar G, Burke TW, Petzold E, Denny T, Woods CW, McVerry BJ, Lee JS, Watkins SC, St. Croix CM, Morris A, Kearney MF, Ladinsky MS, Bjorkman PJ, Kitsios GD, Mellors JWSevere Acute Respiratory Syndrome Coronavirus 2 Viremia Is Associated With Coronavirus Disease 2019 Severity and Predicts Clinical Outcomes2022-05-03Clin Infect DisClin Infect Dis. 2022 May 3;74(9):1525-1533. doi: 10.1093/cid/ciab686.
Howard-Anderson J, Dai W, Yahav D, Hamasaki T, Turjeman A, Koppel F, Franceschini E, Hill C, Sund Z, Chambers HF, Fowler VG Jr., Boucher HW, Evans SR, Paul M, Holland TL, Doernberg SB; on behalf of the Antibacterial Resistance Leadership GroupA Desirability of Outcome Ranking (DOOR) Analysis of a Randomized Clinical Trial Comparing Seven Versus Fourteen Days of Antibiotics for Uncomplicated Gram-Negative Bloodstream Infection2022-04-09Open Forum Infect DisOpen Forum Infect Dis. 2022. ofac140, https://doi.org/10.1093/ofid/ofac140
Patel R, Polage CR, Dien Bard J, May L, Lee F, Fabre V, Hayden MK, Doernberg SDB, Haake DA, Trautner BW, Grigoryan L, Tsalik EL, Hanson KE; on behalf of the Antibacterial Resistance Leadership Group and the Infectious Diseases Society of AmericaEnvisioning Future Urinary Tract Infection Diagnostics2022-04-09Clin Infect DisClin Infect Dis. 2022 Apr 9;74(7):1284-1292. doi: 10.1093/cid/ciab749.
Shropshire WC, Dinh AQ, Earley M, Komarow L, Panesso D, Rydell K, Gomez-Villegas SI, Miao H, Hill C, Chen L, Patel R, Fries BC, Abbo L, Cober E, Revolinski S, Luterbach CL, Chambers H, Fowler VG, Bonomo RA, Shelburne SA, Kreiswirth BN, van Duin D, Hanson BM, Arias CAAccessory Genomes Drive Independent Spread of Carbapenem-Resistant Klebsiella pneumoniae Clonal Groups 258 and 307 in Houston, TX2022-03-31mBiomBio. 2022 Mar 31;e0049722. doi: 10.1128/mbio.00497-22. Online ahead of print.
Pettigrew MM, Kwon J, Gent JF, Kong Y, Wade M, Williams DJ, Creech CB, Evans S, Pan Q, Walter EB, Martin JM, Gerber JS, Newland JG, Howard L, Hofto ME, Staat MA, Fowler VG, Chambers HF, Huskins WC; on behalf of the Antibacterial Leadership Resistance GroupComparison of the respiratory resistome in children receiving short vs. standard course treatment for community acquired pneumonia2022-03-24mBiomBio. 2022 Mar 24;e0019522. doi: 10.1128/mbio.00195-22. Online ahead of print.
Howard-Anderson J, Davis M, page AM, Bower CW, Smith G, Jacob JT, Andersson DI, Weiss DS, Satola SWPrevalence of Colistin Heteroresistance in Carbapenem-Resistant Pseudomonas aeruginosa and Association with Clinical Outcomes in Patients: An Observational Study2022-03-23J Antimicrob ChemotherJ Antimicrob Chemother. 2022 Feb 23;77(3):793-798. doi: 10.1093/jac/dkab461.
Iovleva A, Mustapha MM, Griffith MP, Komarow L, Luterbach C, Cober E, Richter SS, Arias CA, Jacob JT, Salata RA, Satlin MJ, Wong D, Bonomo RA, van Duin D, Cooper VS, Tyne DV, Doi YCarbapenem-Resistant Acinetobacter baumannii in US hospitals: diversification of circulating lineages and antimicrobial resistance2022-03-21mBiomBio. 2022 Mar 21;e0275921. doi: 10.1128/mbio.02759-21. Online ahead of print.
Kwon J, Kong Y, Wade M, Williams DJ, Creech CB, Evans S, Walter EB, Martin JM, Gerber JS, Newland JG, Hofto ME, Staat MA, Fowler VG, Chambers HF, Huskins WC, Pettigrew MM; on behalf of the Antibacterial Resistance Leadership GroupGastrointestinal Microbiome Disruption and Antibiotic-Associated Diarrhea in Children Receiving Antibiotic Therapy for Community-Acquired Pneumonia2022-03-06J Infect DisJ Infect Dis. 2022 Mar 6;jiac082. doi: 10.1093/infdis/jiac082. Online ahead of print.
Williams DJ, Creech CB, Walter EB, Martin JM, Gerber JS, Newland JG, Howard L, Hofto ME, Staat M, Oler RE, Tuyishimire B, Conrad TM, Lee M, Ghazaryan V, Knisely J, Pettigrew MM, Fowler VG, Chambers HF, Zaoutis TE, Evans S, Huskins WC; and the DMID 14-0079 Study TeamShort- vs Standard-Course Outpatient Antibiotic Therapy for Community-Acquired Pneumonia in Children: The SCOUT-CAP Randomized Clinical Trial2022-03-01JAMA PediatrJAMA Pediatr. 2022 Mar 1;176(3):253-261. doi: 10.1001/jamapediatrics.2021.5547.
Thaden J, Tamma P, Pan Q, Doi Y, Daneman NSurvey of Infectious Diseases Providers Reveals Variability in Duration of Antibiotic Therapy for the Treatment of Gram-Negative Bloodstream Infections2022-02-09JAC Antimicrob ResistJAC Antimicrob Resist. 2022 Feb 9;4(1):dlac005. doi: 10.1093/jacamr/dlac005. eCollection 2022 Mar.
Howard-Anderson J, Earley M, Komarow L, Abbo L, Anderson DJ, Gallagher JC, Grant M, Kim A, Bonomo RA, van Duin D, Munoz-Price LS, Jacob JT; The Antibacterial Resistance Leadership GroupPoor outcomes in both infection and colonization with carbapenem-resistant Enterobacterales2022-02-02Infect Control Hosp EpidemiolInfect Control Hosp Epidemiol. 2022 Feb 2;1-7. doi: 10.1017/ice.2022.4. Online ahead of print.
Lodise TP, Scheetz M, Carreno JJ, Chambers H, Fowler V Jr., Holland HL; on behalf of the Antibacterial Resistance Leadership GroupAssociations between Vancomycin Exposure and Acute Kidney Injury Within the Recommended Area Under the Curve Therapeutic Exposure Range Among Patients with MRSA Bloodstream Infections2022-01-22Open Forum Infect DisOpen Forum Infect Dis. 2022 Jan 22;9(2):ofab651. doi: 10.1093/ofid/ofab651. eCollection 2022 Feb.
Howard-Anderson J, Bower CW, Smith G, Satola SW, Jacob JTMortality in Patients with Carbapenem-Resistant Pseudomonas aeruginosa With and Without Susceptibility to Traditional Antipseudomonal β-lactams2021-12-17JAC Antimicrob ResistJAC Antimicrob Resist. 2021 Dec 17;3(4):dlab187. doi: 10.1093/jacamr/dlab187. eCollection 2021 Dec.
Howard-Anderson J, Davis M, page AM, Bower CW, Smith G, Jacob JT, Andersson DI, Weiss DS, Satola SWPrevalence of Colistin Heteroresistance in Carbapenem-Resistant Pseudomonas aeruginosa and Association with Clinical Outcomes in Patients: An Observational Study2021-12-16J Antimicrob ChemotherJ Antimicrob Chemother. 2021 Dec 16;dkab461. doi: 10.1093/jac/dkab461. Online ahead of print.
Ross M, Henao R, Burke TW, Ko ER, McClain MT, Ginsburg GS, Woods CW, Tsalik ELA Comparison of Host Response Strategies to Distinguish Bacterial and Viral Infection2021-12-14PLoS ONEPLoS One. 2021 Dec 14;16(12):e0261385. doi: 10.1371/journal.pone.0261385. eCollection 2021.
Wang M, Earley M, Chen L, Hanson B, Yu Y, Liu Z, Salcedo S, Cober E, Li L, Kanj S, Gao H, Munita J, Ordoñez K, Weston G, Satlin M, Valderrama S, Marimuthu K, Stryjewski ME, Komarow L, Luterbach C, Marshall S, Manca C, Paterson DL, Reyes J, Villegas MV, Evans S, Hill C, Arias R, Baum K, Fries BC, Doi Y, Patel R, Kreiswirth BN, Bonomo RA, Chambers HF, Fowler Jr VG, Arias C, van Duin D for the MDRO InvestigatorsClinical Outcomes and Bacterial Characteristics of Carbapenem-Resistant Klebsiella pneumoniae complex among Patients from Different Global Regions (CRACKLE-2): a Prospective Cohort Study2021-11-09Lancet Infect DisLancet Infect Dis. 2021 Nov 9;S1473-3099(21)00399-6. doi: 10.1016/S1473-3099(21)00399-6. Online ahead of print.
Tsalik EL, Fiorino C, Aqeel A, Liu Y, Henao R, Ko ER, Burke TW, Reller ME, Bodinayake CK, Nagahawatte A, Kodikaraarachchi W, Devasiri V, Kurukulasooriya R, MCClain MT, Woods CW, Ginsburg GS, Tillekeratne G, Schughart KThe host response to viral infections reveals common and virus-specific signatures in the peripheral blood2021-10-27Front ImmunolFront Immunol. 2021 Oct 27;12:741837. doi: 10.3389/fimmu.2021.741837. eCollection 2021.
Tsalik EL, Henao R, Montgomery JL, Nawrocki JW, Aydin M, Lydon EC, Ko ER, Petzold E, Nicholson BP, Cairns CB, Glickman SW, Quackenbush E, Kingsmore SF, Jaehne AK, Rivers EP, Langley RJ, Fowler VG, McClain MT, Crisp RJ, Ginsburg GS, Burke T, Hemmert AC, Woods CW; and the Antibacterial Resistance Leadership GroupDiscriminating Bacterial and Viral Infection Using a Rapid Host Gene Expression Test2021-10-01Crit Care MedCrit Care Med. 2021 Oct 1;49(10):1651-1663. doi: 10.1097/CCM.0000000000005085.
Mumma JM, Howard-Anderson J, Morgan J, Schink K, Wheatley MJ, Kraft C, Lane M, Kaufman N, Ayeni O, Brownsword EA, Jacob JTHealthcare Worker Mental Models of Patient Care Tasks in the Context of Infection Prevention and Control2021-09-10Infect Control Hosp EpidemiolInfect Control Hosp Epidemiol. 2021 Sep 10;1-6. doi: 10.1017/ice.2021.368. Online ahead of print.
Patel R, Polage CR, Dien Bard J, May L, Lee F, Fabre V, Hayden MK, Doernberg SDB, Haake DA, Trautner BW, Grigoryan L, Tsalik EL, Hanson KE; on behalf of the Antibacterial Resistance Leadership Group and the Infectious Diseases Society of AmericaEnvisioning Future UTI Diagnostics2021-08-31Clin Infect DisClin Infect Dis. 2021 Aug 31;ciab749. doi: 10.1093/cid/ciab749. Online ahead of print.
Goldberg JA, Kumar V, Spencer EJ, Hoyer D, Marshall SH, Hujer AM, Hujer KM, Bethel CR, Papp-Wallace KM, Perez F, Jacobs MR, van Duin D, Kreiswirth BN, van den Akker F, Plummer MS, Bonomo RAA γ-lactam siderophore antibiotic effective against multidrug-resistant Pseudomonas aeruginosa, Klebsiella pneumoniae, and Acinetobacter spp.2021-06-21Eur J Med ChemEur J Med Chem. 2021 Aug 5;220:113436. doi: 10.1016/j.ejmech.2021.113436. Epub 2021 Apr 8.
King HA, Doernberg SB, Grover K, Miller J, Oakes M, Wang T-W, McFatrich M, Ruffin F, Staman K, Sund Z, Bosworth HB, Reeve BB, Fowler VG Jr., Holland TL; on behalf of the Antibacterial Resistance Leadership GroupPatients’ Experiences with Staphylococcus aureus and Gram-Negative Bacterial Bloodstream Infections: Results of Cognitive Interview Phase to Inform Measurement of Patient-Reported Quality of Life2021-05-23Clin Infect DisClin Infect Dis. 2020 May 23;ciaa611. doi: 10.1093/cid/ciaa611. Online ahead of print.
Tsalik EL, Henao R, Montgomery JL, Nawrocki JW, Aydin M, Lydon EC, Ko ER, Petzold E, Nicholson BP, Cairns CB, Glickman SW, Quackenbush E, Kingsmore SF, Jaehne AK, Rivers EP, Langley RJ, Fowler VG, McClain MT, Crisp RJ, Ginsburg GS, Burke T, Hemmert AC, Woods CW; and the Antibacterial Resistance Leadership GroupDiscriminating Bacterial and Viral Infection Using a Rapid Host Gene Expression Test2021-04-28Crit Care MedCrit Care Med. 2021 Apr 28. doi: 10.1097/CCM.0000000000005085. Online ahead of print.
Modlin C, Howard-Anderson J, Greer A, Marchioli C, Waller E, Mehta A, Burd E, Kraft CS, Babiker APhoto Quiz: Strength in Numbers-a Disseminated Infection Causing Shortness of Breath2021-04-20J Clin MicrobiolJ Clin Microbiol. 2021 Apr 20;59(5):e01316-20. doi: 10.1128/JCM.01316-20.
Queen J, Karaba S, Albin J, Karaba A, Howard-Anderson J, Platt L, Skinner N, Herman J, Paras ML, Melia MTThe Time is Now: A Call for Renewed Support of Infectious Disease Physician-Scientist Trainees in the COVID-19 Era2021-03-26J Infect DisJ Infect Dis. 2021 Mar 26;jiab162. doi: 10.1093/infdis/jiab162. Online ahead of print.
Lodise TP, Van Wart S, Sund ZM, Bressler AM, Khan A, Makley AT, Hamad Y, Salata RA, Silveira FP, Sims MD, Kabchi BA, Saad MA, Brown C, Oler RE Jr, Fowler V Jr, Wunderink RGPharmacokinetic and Pharmacodynamic Profiling of Minocycline for Injection Following a Single Infusion in Critically Ill Adults in a Phase IV Open-Label Multi-Center Study (ACUMIN)2021-02-17Antimicrob Agents ChemotherAntimicrob Agents Chemother. 2021 Feb 17;65(3):e01809-20.
Chambers HF, Evans SR, Patel R, Cross HR, Harris AD, Doi Y, Boucher H, van Duin D, Tsalik EL, Holland TL, Pettigrew M, Tamma P, Hodges KR, Souli M, Fowler VGAntibacterial Resistance Leadership Group 2.0 – Back to Business2021-02-15Clin Infect DisClin Infect Dis. 2021 Feb 15;ciab141. doi: 10.1093/cid/ciab141. Online ahead of print.
Howard-Anderson J, Adams C, Sherman AC, Dube WC, Smith TC, Edupuganti N, Chea N, Magill SS, Espinoza DO, Zhu Y, Phadke VK, Edupuganti S, Steinberg JP, Lopman BA, Jacob JT, Collins MH, Fridkin SKOccupational Risk Factors for SARS-CoV-2 infection among Healthcare Personnel: A Cross-Sectional Analysis of Subjects Enrolled in the COPE Study2021-02-09Infect Control Hosp EpidemiolInfect Control Hosp Epidemiol. 2021Feb 9;1-20. doi: 10.1017/ice.2021.54.
Nematollahi S, Konold V, Gaston D, Howard-Anderson J, Kiley J, Masters MC, Melia MT, Balba GP, Chiang A, Gupta NImpact of COVID-19 on Infectious Diseases Fellows in the United States: Perspectives from the First National ID Fellows Call2021-01-28Open Forum Infect DisOpen Forum Infect Dis. 2021 Jan 28;8(2):ofab021. doi: 10.1093/ofid/ofab021. eCollection 2021 Feb.
Howard-Anderson J, Bower CW, Smith G, Sexton ME, Farley MM, Satola SW, Jacob JTCarbapenem-Resistant Enterobacterales Bacteriuria and Subsequent Bacteremia: A Population-based Study2020-12-10Infect Control Hosp EpidemiolInfect Control Hosp Epidemiol. 2020 Dec 10;1-6. doi: 10.1017/ice.2020.1325. Online ahead of print.
Doernberg SB, Komarow L, Tran TTT, Sund Z, Pandori MW, Jensen D, Tsalik EL, Deal CD, Chambers HF, Fowler VG, Evans SR, Patel R, Klausner JDSimultaneous Evaluation of Diagnostic Assays for Pharyngeal and Rectal Neisseria gonorrhoeae and Chlamydia trachomatis Using a Master Protocol2020-12-03Clin Infect DisClin Infect Dis. 2020 Dec 3;71(9):2314-2322.
Amoah J, Stuart EA, Cosgrove SE, Harris AD, Han JH, Lautenbach E, Tamma PDComparing Propensity Score Methods Versus Traditional Regression Analysis for the Evaluation of Observational Data: A Case Study Evaluating the Treatment of Gram-Negative Bloodstream Infections2020-12-03Clin Infect DisClin Infect Dis. 2020 Dec 3;71(9):e497-e505.
Lodise TP, Van Wart S, Sund ZM, Bressler AM, Khan A, Makley AT, Hamad Y, Salata RA, Silveira FP, Sims MD, Kabchi BA, Saad MA, Brown C, Oler RE Jr, Fowler V Jr, Wunderink RGPharmacokinetic and Pharmacodynamic Profiling of Minocycline for Injection Following a Single Infusion in Critically Ill Adults in a Phase IV Open-Label Multi-Center Study (ACUMIN)2020-11-09Antimicrob Agents ChemotherAntimicrob Agents Chemother. 2020 Nov 9;AAC.01809-20. doi: 10.1128/AAC.01809-20.
Tanaka JS, Young RR, Heston SM, Jenkins K, Spees LP, Sung AD, Corbet K, Thompson J, Bohannon L, Martin PL, Vinesett R, Ward DV, Bhattarai SK, Bucci V, Seed PC, Kelly MSAnaerobic Antibiotics and the Risk of Graft-Versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation2020-11-02Biol Blood Marrow TransplantBiol Blood Marrow Transplant. 2020 Nov;26(11):2053-2060. doi: 10.1016/j.bbmt.2020.07.011. Epub 2020 Jul 17.
Howard-Anderson J, Bower CW, Smith G, Sexton ME, Farley MM, Satola SW, Jacob JTCarbapenem-Resistant Enterobacterales Bacteriuria and Subsequent Bacteremia: A Population-based Study2020-12-10Infect Control Hosp EpidemiolInfect Control Hosp Epidemiol. 2020 Dec 10;1-6. doi: 10.1017/ice.2020.1325. Online ahead of print.
Doernberg SB, Komarow L, Tran TTT, Sund Z, Pandori MW, Jensen D, Tsalik EL, Deal CD, Chambers HF, Fowler VG, Evans SR, Patel R, Klausner JDSimultaneous Evaluation of Diagnostic Assays for Pharyngeal and Rectal Neisseria gonorrhoeae and Chlamydia trachomatis Using a Master Protocol2020-12-03Clin Infect DisClin Infect Dis. 2020 Dec 3;71(9):2314-2322.
Amoah J, Stuart EA, Cosgrove SE, Harris AD, Han JH, Lautenbach E, Tamma PDComparing Propensity Score Methods Versus Traditional Regression Analysis for the Evaluation of Observational Data: A Case Study Evaluating the Treatment of Gram-Negative Bloodstream Infections2020-12-03Clin Infect DisClin Infect Dis. 2020 Dec 3;71(9):e497-e505.
Lodise TP, Van Wart S, Sund ZM, Bressler AM, Khan A, Makley AT, Hamad Y, Salata RA, Silveira FP, Sims MD, Kabchi BA, Saad MA, Brown C, Oler RE Jr, Fowler V Jr, Wunderink RGPharmacokinetic and Pharmacodynamic Profiling of Minocycline for Injection Following a Single Infusion in Critically Ill Adults in a Phase IV Open-Label Multi-Center Study (ACUMIN)2020-11-09Antimicrob Agents ChemotherAntimicrob Agents Chemother. 2020 Nov 9;AAC.01809-20.
doi: 10.1128/AAC.01809-20.
Tanaka JS, Young RR, Heston SM, Jenkins K, Spees LP, Sung AD, Corbet K, Thompson J, Bohannon L, Martin PL, Vinesett R, Ward DV, Bhattarai SK, Bucci V, Seed PC, Kelly MSAnaerobic Antibiotics and the Risk of Graft-Versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation2020-11-02Biol Blood Marrow TransplantBiol Blood Marrow Transplant. 2020 Nov;26(11):2053-2060. doi: 10.1016/j.bbmt.2020.07.011. Epub 2020 Jul 17.
Almulhim AM, Vellozzi-Averhoff CM, Howard-Anderson J, Babiker A, Kraft CSPhoto Quiz: Bilateral Necrotizing Pneumonia In a 30-Year-Old Woman, a Hairy Situation2020-10-21J Clin MicrobiolJ Clin Microbiol. 2020 Oct 21;58(11):e00451-20. doi: 10.1128/JCM.00451-20.
Hujer AM, Hujer KM, Leonard DA, Powers RA, Wallar BJ, Mack AR, Taracila MA, Rather PN, Higgins PG, Prati F, Caselli E, Marshall SH, Clarke T, Greco C, Venepally P, Brinkac L, Kreiswirth BN, Fouts DE, Bonomo RA for the Antibacterial Resistance Leadership Group (ARLG)A Comprehensive and Contemporary "Snapshot" of Beta-lactamases in Carbapenem Resistant Acinetobacter Baumannii2020-10-16Diagn Microbiol Infect DisDiagn Microbiol Infect Dis. 2020 Oct 16;99(2):115242.
Steed DB, Wang T, Raheja D, Waldman AD, Babiker A, Dhere T, Kraft CS, Woodworth MHGram-Negative Taxa and Antimicrobial Susceptibility after Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection2020-10-14mSpheremSphere. 2020 Oct 14;5(5):e00853-20. doi: 10.1128/mSphere.00853-20.
Anesi JA, B+2:6lumberg EA, Han JH, Lee DH, Clauss H, Climaco A, Hasz R, Molnar E, Alimenti D, West S, Bilker WB, Tolomeo P, Lautenbach ERisk factors for multidrug-resistant organisms among deceased organ donors2020-09-04Am J TransplantAm J Transplant. 2019 Sep;19(9):2468-2478. doi: 10.1111/ajt.15488. Epub 2019 Jun 26.
Lodise TP, Smith NM, O'Donnell N, Eakin AE, Holden PN, Boissonneault KR, Zhou J, Tao X, Bulitta JB, Fowler Jr VG, Chambers HF, Bonomo RA, Tsuji BTDetermining the optimal dosing of a novel combination regimen of ceftazidime/avibactam with aztreonam against NDM-1-producing Enterobacteriaceae using a hollow-fibre infection model2020-09-01J Antimicrob ChemotherJ Antimicrob Chemother. 2020 Sep 1;75(9):2622-2632. doi: 10.1093/jac/dkaa197.
O'Donnell JN, Xu A, Lodise TPIntravenous Compatibility of Ceftazidime-Avibactam plus Aztreonam using Simulated and Actual Y-site Administration2020-08-07Clin TherClin Ther. 2020 Aug;42(8):1580-1586.e2. doi: 10.1016/j.clinthera.2020.06.005. Epub 2020 Jul 16.
Howard-Anderson J, Webster A, Goyal A, Vadnais DS, Kraft CS, Steinberg JP, Jacob JTCOVID-19 or Common Coronavirus? A Cautionary Tale in Advanced Diagnostics2020-07-25Diagnosis (Berl)Diagnosis (Berl). 2020 Jul 25;/j/dx.ahead-of-print/dx-2020-0093/dx-2020-0093.xml. doi: 10.1515/dx-2020-0093. Online ahead of print.
Tanaka JS, Young RR, Heston SM, Jenkins K, Spees LP, Sung AD, Corbet K, Thompson J, Bohannon L, Martin PL, Vinesett R, Ward DV, Bhattarai SK, Bucci V, Seed PC, Kelly MSAnaerobic Antibiotics and the Risk of Graft-Versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation2020-07-16Biol Blood Marrow TransplantBiol Blood Marrow Transplant. 2020;S1083-8791(20)30442-0. doi: 10.1016/j.bbmt.2020.07.011. Online ahead of print.
King HA, Doernberg SB, Miller J, Grover K, Oakes M, Ruffin F, Gonzales S, Rader A, Neuss MJ, Bosworth HB, Sund Z, Fowler VG Jr., Holland TLPatients’ Experiences with Staphylococcus aureus and Gram-Negative Bacterial Bloodstream Infections: A Qualitative Descriptive Study and Concept Elicitation Phase to Inform Measurement of Patient-Reported Quality of Life2020-05-23Clin Infect DisClin Infect Dis. 2020 May 23;ciaa611. doi: 10.1093/cid/ciaa611. Online ahead of print.
Banerjee R, Komarow L, Virk A, Rajapakse N, Schuetz A, Dylla B, Earley M, Lok J, Kohner P, Ihde S, Cole N, Hines L, Reed K, Garner O, Chandrasekaran S, de St. Maurice A, Kanatani M, Curello J, Arias R, Swearingen W, Doernberg SB, Patel R; for the Antibacterial Leadership Resistance GroupRandomized trial evaluating clinical impact of RAPid IDentification and Susceptibility testing for Gram Negative bacteremia (RAPIDS-GN)
2020-05-07
Clin Infect Dis
Clin Infect Dis. 2020 May 7. pii: ciaa528. doi: 10.1093/cid/ciaa528. [Epub ahead of print]
J, Arias R, Swearingen W, Doernberg SB, Patel R; for the Antibact (Seed Grant, Trialist in Training)
Core Genome MLST and Resistome Analysis of Klebsiella pneumoniae Using a Clinically-Amenable Workflow
2020-05-01
Diagn Microbiol Infect Dis
Diagn Microbiol Infect Dis. 2020 May;97(1):114996. doi: 10.1016/j.diagmicrobio.2020.114996. Epub 2020 Jan 21
Jacobs MR, Good CE, Hujer AM, Abdelhamed AM, Rhoads DD, Hujer KM, Rudin SD, Domitrovic TN, Connolly L, Krause KM, Patel R, Kreiswirth BN, Rojas LJ, Brinkac LM, Fouts DE, van Duin D, Bonomo RA; for the Antibiotic Resistance Leadership GroupARGONAUT II Study of the in vitro activity of plazomicin against carbapenemase-producing Klebsiella pneumoniae2020-04-21Antimicrob Agents ChemotherAntimicrob Agents Chemother. 2020 Apr 21;64(5). pii: e00012-20. doi: 10.1128/AAC.00012-20. Print 2020 Apr 21.
Adamson PC, Pandori MW, Doernberg SB, Komarow L, Sund Z, Tran TTT, Jensen D, Tsalik EL, Deal CD, Chambers HF, Fowler VG, Evans SR, Patel R, Klausner JD; for the Master GC Study of the Antibacterial Resistance Leadership GroupAnalytical evaluation of the Abbott RealTime CT/NG Assay for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in rectal and pharyngeal swabs
2020-04-01
J Mol Diagn
J Mol Diagn. 2020 Apr 2. pii: S1525-1578(20)30074-X. doi: 10.1016/j.jmoldx.2020.03.004. [Epub ahead of print]
van Duin D, Arias CA, Komarow L, Chen L, Hanson B, Weston G, Ostrowsky B, Cober E, Richter SS, Garner OB, Jacob JT, Satlin MJ, Fries BC, Garcia-Diaz J, Doi Y,Dhar S, Kaye KS, Desai S, Kim A, Gallagher JC, Salata RA, Han JH, Wortmann G, Abbo L, Patel R, Wong D, Patel G, Anderson DJ, Kalayjian RC, Grant M, Munoz-Price LS, Eilertson B, Farrell JJ, Eiras DP, Earley M, Lok J, Marshall S, Rudin, Domitrovic TN, Hujer AM, Hujer KM, Perez F, Dinh A, Shropshire W, Panesso D, Tran TT, Manca C, Mediavilla JR, Wang M, Paterson DL, Banerjee R, Evans S, Hill C, Arias R, Chambers HF, Fowler VG, Kreiswirth BN, Bonomo RAMolecular and clinical epidemiology of carbapenem-resistant Enterobacterales in the USA (CRACKLE-2): a prospective cohort study
2020-03-06
The Lancet Infectious Diseases
The Lancet Infectious Diseases, 2020, ISSN 1473-3099, doi.org/10.1016/S1473-3099(19)30755-8.
Turner N, Anderson DJ
Hospital Infection Control: Clostridioides difficile
2020-03-02
Clin Colon Rectal Surg
Clin Colon Rectal Surg. 2020 Mar;33(2):98-108. doi: 10.1055/s-0040-1701234. Epub 2020 Feb 25.
Anesi JA, Lautenbach E, Tamma P, Thorn K, Blumberg EA, Alby K, Bilker WB, Werzen A, Tolomeo P, Omorogbe J, Pineles L, Han JH
Risk factors for extended-spectrum beta-lactamase-producing Enterobacterales bloodstream infection among solid organ transplant recipients
2020-02-28
Clin Infect Dis
Clin Infect Dis. 2020 Feb 28. pii: ciaa190. doi: 10.1093/cid/ciaa190. [Epub ahead of print]
Amoah J, Stuart EA, Cosgrove SE, Han JH, Harris AD, Lautenbach E, Tamma PD
Comparing Propensity Score Methods versus Traditional Regression Analysis for the Evaluation of Observational Data: A Case Study Evaluating the Treatment of Gram-Negative Bloodstream Infections
2020-02-18
Clin Infect Dis
Clin Infect Dis. 2020 Feb 18. pii: ciaa169. doi: 10.1093/cid/ciaa169. [Epub ahead of print]
Core genome MLST and resistome analysis of Klebsiella pneumoniae using a clinically amenable workflow
Core genome MLST and resistome analysis of Klebsiella pneumoniae using a clinically amenable workflow
2020-01-21
Diagn Microbiol Infect Dis
Diagn Microbiol Infect Dis. 2020;114996. doi:10.1016/j.diagmicrobio.2020.114996, 114996 2020 Jan 21.

Wenzler E, Meyer KM, Bleasdale SC, Sikka M, Mendes RE, Bunnell KL, Finnemeyer M, Rosenkranz SL, Danziger LH, Rodvold KA; for the Antibacterial Resistance Leadership GroupEx Vivo Urinary Bactericidal Activity and Urinary Pharmacodynamics of Fosfomycin After Two Repeated Dosing Regimens of Oral Fosfomycin Tromethamine in Healthy Adult Subjects
2019-11-25
Antimicrob Agents Chemother
Antimicrob Agents Chemother. 2019 Nov 25. pii: AAC.02102-19. doi: 10.1128/AAC.02102-19. [Epub ahead of print]
Doernberg SB, Komarow L, Tran TT, Sund Z, Pandori MW, Jensen D, Tsalik EL, Deal CD, Chambers HF, Fowler VG, Evans SR, Patel R, Klausner JDA Master Protocol for Simultaneous Evaluation of Multiple Diagnostic Assays to Detect Neisseria gonorrhoeae and Chlamydia trachomatis in Extragenital Sites: MASTER GC
2019-11-17
Clin Infect Dis
Clin Infect Dis. 2019 Nov 17. pii: ciz1105. doi: 10.1093/cid/ciz1105. [Epub ahead of print]
Tsalik EL, Khine A, Talebpour S, Samiei A, Parmar V, Burke T, McClain MT, Ginsburg GS, Woods CW, Henao R, Alavie T
Rapid, Sample-to-Answer Host Gene Expression Test to Diagnose Viral Infection
2019-10-30
Open Forum Infect Dis
Open Forum Infectious Diseases, Volume 6, Issue 11, November 2019, ofz466, https://doi.org/10.1093/ofid/ofz466
Lydon EC, Henao R, Burke TW, Aydin M, Nicholson BP, Glickman SW, Fowler VG, Quackenbush EB, Cairns CB, Kingsmore SF, Jaehne AK, Rivers EP, Langley R, Petzold E, Ko ER, McClain MT, Ginsburg GS, Woods CW, Tsalik EL
Validation of a host response test to distinguish bacterial and viral respiratory infection
2019-10-17
EBioMedicine
EBioMedicine. 2019 Oct;48:453-461. doi: 10.1016/j.ebiom.2019.09.040. Epub 2019 Oct 17.
Turner N, Grambow S, Woods CW, Moehring R, Anderson DJ, Lewis S
Epidemiologic Trends in Clostridioides difficile Infections within a Regional Community Hospital Network
2019-10-02
JAMA Network Open
JAMA Netw Open. 2019 Oct 2;2(10):e1914149. doi: 10.1001/jamanetworkopen.2019.14149.
Aslam S, Courtwright AM, Koval C, Lehman SM, Morales S, Langlais Furr CL, Rosas F, Brownstein MJ, Fackler JR, Sisson BM, Biswas B, Henry M, Luu T, Bivens BN, Hamilton T, Duplessis C, Logan C, Law N, Yung G, Turowski J, Anesi J, Strathdee SA, Schooley RT
Early clinical experience of bacteriophage therapy in 3 lung transplant recipients
2019-09-01
Am J TransplantAm J Transplant. 2019;19(9):2631–2639. doi:10.1111/ajt.15503
Anderson DJ, Watson S, Moehring RW, Komarow L, Finnemeyer M, Arias RM, Huvane J, Bova Hill C, Deckard N, Sexton DJFeasibility of Core Stewardship Interventions in Community Hospitals: a multicenter, historically-controlled study with crossover design2019-8-2JAMA Network Open https://www.ncbi.nlm.nih.gov/pubmed/31418804
Kelly MS, Ward DV, Severyn CJ, Arshad M, Heston SM, Jenkins K, Martin PL, McGill L, Stokhuyzen A, Bhattarai SK, Bucci V, Seed PCGut Colonization Preceding Mucosal Barrier Injury Bloodstream Infection in Pediatric Hematopoietic Stem Cell Transplant Recipients2019-7-18Biol Blood Marrow Transplanthttps://www.ncbi.nlm.nih.gov/pubmed/31326608
Woodworth MH, Hayden MK, Young VB, Dantas G, Kwon JHThe role of fecal microbiota transplantation to reduce intestinal colonization with antibiotic-resistant organisms: the current landscape and future directions2019-6-22Open Forum Infect Dishttps://www.ncbi.nlm.nih.gov/pubmed/31363779
Collins JM, Wallender EK, Woodworth MHImproving the ID clinical scientist workforce from the view of junior investigators: vision, transparency, and reproducibility2019-6-20Clin Infect Dishttps://www.ncbi.nlm.nih.gov/pubmed/31231765
Henderson H, Luterbach CL, Cober E, Richter SS, Salata RA, Kalayjian RC, Watkins RR, Doi Y, Kaye KS, Evans S, Fowler VG, Bonomo RA, Harris A, Napravnik S, van Duin DThe Pitt Bacteremia Score Predicts Mortality in Non-Bacteremic Infections
(Former title: Optimizing Prediction of Mortality in Patients Infected with Carbapenem-resistant Enterobacteriaceae)
2019-6-19Clin Infect Dishttps://www.ncbi.nlm.nih.gov/pubmed/31219148
Lodise TP, Rosenkranz SL, Finnemeyer M, Evans S, Sims M, Zervos MJ, Creech CB, Patel PC, Keefer M, Riska P, Silveira FP, Scheetz M, Wunderink RG, Rodriguez M, Schrank J, Bleasdale SC, Schultz S, Barron M, Stapleton A, Wray D, Chambers H, Fowler V, HollandThe Emperor's New Clothes: Prospective Observational Evaluation of the Association between the Day 2 Vancomycin Exposure and Failure Rates among Adult Hospitalized Patients with MRSA Bloodstream Infections (PROVIDE)2019-6-14Clin Infect DisClin Infect Dis. 2019 Jun 3. pii: ciz460. doi: 10.1093/cid/ciz460
Anesi JA, Blumberg EA, Han JH, Lee DH, Clauss H, Climaco A, Hasz R, Molnar E, Alimenti D, West S, Bilker WB, Tolomeo P, Lautenbach E Risk factors for multidrug-resistant organisms among deceased organ donors2019-6-4Am J TransplantAm J Transplant. 2019 Jun 4. doi: 10.1111/ajt.15488
Woodworth MH, Dynerman D, Crawford ED, Doernberg SB, Ramirez-Avila L, Serpa PH, Nichols A, Li LM, Lyden A, Tato CM, Miller S, Derisi JL, Langelier CSentinel Case of Candida auris in the Western United States Following Prolonged Occult Colonization in a Returned Traveler from India2019-6-1Microb Drug Resisthttps://www.ncbi.nlm.nih.gov/pubmed/31163013
Pholwat S, Liu J, Taniuchi M, Chinli R, Pongpan T, Thaipisutikul I, Ratanakorn P, Platts-Mills J, Fleece M, Stroup S, Gratz J, Mduma E, Mujaga B, Walongo T, Nshama R, Kimathi C, Foongladda S, Houpt E Genotypic antimicrobial resistance (AMR) assays for use on E. coli isolates and direct stool specimens2019-5-10PLoS ONEPLoS One. 2019 May 10;14(5):e0216747. doi: 10.1371/journal.pone.0216747
Perez F, El Chakhtoura NG, Yasmin M, Bonomo RAPolymyxins: To Combine or Not to Combine?2019-4-10Antibioticshttps://www.ncbi.nlm.nih.gov/pubmed/30974813
Mulliken JS, Langelier C, Budak JZ, Miller S, Dynerman D, Hao S, Li LM, Crawford E, Lyden A, Woodworth MH, DeRisi JL, Desmond E, Browne C, Luu A, Grandis DJ, Grossman W, Deuse T,
Melcher GP
Bergeyella cardium: Clinical Characteristics and Draft Genome of an Emerging Pathogen in Native and Prosthetic Valve Endocarditis2019-3-15Open Forum Infect DisOpen Forum Infect Dis. 2019 Mar 15;6(4):ofz134. doi: 10.1093/ofid/ofz134.
Liss MA, Leach RJ, Rourke E, Sherrill A, Johnson-Pais T, Lai Z, Basler J, White JR, Patterson JEMicrobiome diversity in carriers of fluoroquinolone resistant Escherichia coli2019-3-4Investig Clin UrolInvestig Clin Urol. 2019 Mar;60(2):75-83. doi: 10.4111/icu.2019.60.2.75. Epub 2019 Feb 27
Turner N, Strand A, Grewal D, Cox G, Arif S, Baker AW, Maziarz EK, Saullo JH, Wolfe CR.Use of Letermovir as Salvage Therapy for Drug-resistant CMV: A Case Series2019-3-1Antimicrob Agents ChemotherAntimicrob Agents Chemother. 2019 Feb 26;63(3). pii: e02337-18. doi: 10.1128/AAC.02337-18. Print 2019 Mar
Holland TL, Chambers HF, Boucher HW, Corey GR, Coleman R, Castaneda-Ruiz B, Fowler VG JrConsiderations for Clinical Trials of Staphylococcus aureus Bloodstream Infection in Adults2019-2-15Clin Infect DisClin Infect Dis. 2019 Feb 15;68(5):865-872. doi: 10.1093/cid/ciy774
Anesi JA, Lautenbach E, Nachamkin I, Garrigan C, Bilker WB, Omorogbe J, Dankwa L, Wheelter M, Tolomeo P, Han JHThe role of extended-spectrum cephalosporin-resistance in recurrent community-onset Enterobacteriaceae urinary tract infections: a retrospective cohort study2019-2-14BMC Infect DisBMC Infect Dis. 2019 Feb 14;19(1):163. doi: 10.1186/s12879-019-3804-y
Cheng YW, Phelps E, Ganapini V, Khan N, Ouyang F, Xu H, Khanna S, Tariq R, Friedman-Moraco RJ, Woodworth MH, Dhere T, Kraft CS, Kao D, Smith J, Le L, El-Nachef N, Kaur N, Kowsika S, Ehrlich A, Smith M, Safdar N, Misch EA, Allegretti JR, Flynn A, Kassam Z, Sharfuddin A, Vuppalanchi R, Fischer MFecal microbiota transplantation for the treatment of recurrent and severe Clostridium difficile infection in solid organ transplant recipients: A multicenter experience2019-2-1Am J TransplantAm J Transplant. 2018 Aug 7. doi: 10.1111/ajt.15058. [Epub ahead of print]
Jacobs MR, Abdelhamed AM, Good CE, Rhoads DD, Hujer KM, Hujer AM, Domitrovic TN, Rudin SD, Fouts DE, Richter SS, van Duin D, Kreiswirth BN, Bonomo RAARGONAUT-I: Activity of cefiderocol (S-649266), a siderophore cephalosporin, against Gram negative bacteria including carbapenem resistant nonfermenters and Enterobacteriaceae with defined extended-spectrum ?-lactamases and carbapenemases2018-12-21Antimicrob Agents ChemotherAntimicrob Agents Chemother. 2018 Dec 21;63(1). pii: e01801-18. doi: 10.1128/AAC.01801-18. Print 2019 Jan.
Luterbach CL, Boshe A, Henderson H, Cober E, Richter SS, Salata RA, Kalayjian RC, Watkins RR, Hujer AM, Hujer KM, Rudin SD, Domitrovic TN, Doi Y, Kaye KS, Evans S, Fowler VG, Bonomo RA, van Duin DThe Role of Trimethoprim/Sulfamethoxazole in the Treatment of Infections Caused by Carbapenem-Resistant Enterobacteriaceae2018-12-14Open Forum Infect DisOpen Forum Infect Dis. 2018 Dec 14;6(1):ofy351. doi: 10.1093/ofid/ofy351. eCollection 2019 Jan.
Anesi JA, Lautenbach E, Nachamkin I, Garrigan C, Bilker WB, Omorogbe J, Dankwa L, Wheeler MK, Tolomeo P, Han JH; CDC Prevention Epicenters Program.Poor clinical outcomes associated with community-onset urinary tract infections due to extended-spectrum cephalosporin-resistant Enterobacteriaceae2018-12-1Infect Control Hosp EpidemiolInfect Control Hosp Epidemiol. 2018 Dec;39(12):1431-1435. doi: 10.1017/ice.2018.254. Epub 2018 Oct 30.
Evans S, Rubin DB, Powers JH, Follmann.Analysis Populations in Anti-Infective Clinical Trials: Whom to Analyze?2018-12-1Stat Commun Infect DisStat Commun Infect Dis. 2018 Dec;10(1). pii: 20170002. doi: 10.1515/scid-2017-0002. Epub 2018 Aug 29
van Duin D, Gu P, Dong J, Pfaff M, Arias RM, Evans B, Yu Y, Li L, Zhang F, Liu Z, Cao B, Fowler VG, Wang MChina-United States Research Collaborations in Antimicrobial Resistance2018-11-14Clin Infect DisClin Infect Dis. 2018 Nov 13;67(suppl_2):S142-S145. doi: 10.1093/cid/ciy694.
Golpisamy SN, Woodworth MH,Wang T, Carpentieri C, Friedman-Moraco R, Mehta A, Larsen C, Kraft CThe use of microbiome restoration therapeutics to eliminate intestinal colonization with multi-drug resistant organisms2018-11-1Am J Med SciAm J Med Sci. 2018 Nov;356(5):433-440. doi: 10.1016/j.amjms.2018.08.015. Epub 2018 Aug 29.
Evans SR, Follmann D, Liu Y, Holland T, Doernberg SB, Rouphael N, Hamasaki T, Hiang Y, Lok JJ, Tran TTT, Harris AD, Fowler VG, Boucher H, Kreiswirth BN, Bonomo RA, van Duin D, Paterson DL, Chambers H Sequential Multiple Assignment Randomized Trials for COMparing Personalized Antibiotic StrategieS (SMART-COMPASS)2018-10-23Clin Infect DisClin Infect Dis. 2018 Oct 23. doi: 10.1093/cid/ciy912
Doernberg SB, Tran TT, , Davis JS, Paul M, Yahav D, Tong SYC, Leibovici L, Boucher HW, Corey GR, Cosgrove SE, Chambers HF, Fowler VG, Evans SR, and Holland TL Good studies evaluate the disease while great studies evaluate the patient: Development and application of a DOOR endpoint for Staphylococcus aureus bloodstream infection2018-10-12Clin Infect DisClin Infect Dis. 2018 Oct 12. doi: 10.1093/cid/ciy766
Evans SR, Tran TT, Hujer AM, Hill CB, Hujer KM, Mediavilla JR, Manca C, Domitrovic TN, Kreiswirth BN, Patel R, Jacobs MR, Chen L, Sampath R, Hall T, Marzan C, Fowler VG, Chambers HF, Bonomo RA Rapid Molecular Diagnostics to Inform Empiric Use of Ceftazidime/Avibactam and Ceftolozane/Tazobactam against Pseudomonas aeruginosa: PRIMERS IV2018-9-20Clin Infect DisClin Infect Dis. 2018 Sep 20. doi: 10.1093/cid/ciy801
Patel R, Fang FCDiagnostic Stewardship: Opportunity for a Laboratory-Infectious Diseases Partnership2018-8-16Clin Infect DisClin Infect Dis. 2018 Aug 16;67(5):799-801. doi: 10.1093/cid/ciy077.
Wenzler E, Bleasdale SC, Sikka M, Bunnell KL, Finnemeyer M, Rosenkranz SL, Danziger LH, Rodvold KA; Antibacterial Resistance Leadership Group.Phase I Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Two Dosing Regimens of Oral Fosfomycin Tromethamine in Healthy Adult Participants (PROOF)2018-7-27Antimicrob Agents ChemotherAntimicrob Agents Chemother. 2018 Jul 27;62(8). pii: e00464-18. doi: 10.1128/AAC.00464-18. Print 2018 Aug.
Kebriaei R, Rice SA, Singh KV, Stamper KC, Dinh AQ, Rios R, Diaz L, Murray BE, Munita JM, Tran TT, Arias CA, Rybak MJInfluence of Inoculum Effect on the Efficacy of Daptomycin Monotherapy and in Combination with ?-Lactams against Daptomycin-Susceptible Enterococcus faecium Harboring LiaSR Substitutions2018-7-27Antimicrob Agents ChemotherAntimicrob Agents Chemother. 2018 Jul 27;62(8). pii: e00315-18. doi: 10.1128/AAC.00315-18. Print 2018 Aug.
Tamma PD, Pierce VM, Cosgrove SE, Lautenbach E, Harris AD, Rayapati D, Han JHCan the Ceftriaxone Breakpoints be Increased without Compromising Patient Outcomes?2018-6-8Open Forum Infect DisOpen Forum Infect Dis. 2018 Jun 8;5(6):ofy139. doi: 10.1093/ofid/ofy139. eCollection 2018 Jun.
Miller WR, Seas C, Carvajal LP, Diaz L, Echeverri AM, Ferro C, Rios R, Porras P, Luna C, Gotuzzo E, Munita JM, Nannini E, Carcamo C, Reyes J, Arias CAThe Cefazolin Inoculum Effect Is Associated With Increased Mortality in Methicillin-Susceptible Staphylococcus aureus Bacteremia2018-5-23Open Forum Infect DisOpen Forum Infect Dis. 2018 May 23;5(6):ofy123. doi: 10.1093/ofid/ofy123. eCollection 2018 Jun 1.
Mamo Y, Woodworth MH, Wang T, Dhere T, Kraft CSDurability and Long-term Clinical Outcomes of Fecal Microbiota Transplant Treatment in Patients With Recurrent Clostridium difficile Infection2018-5-17Clin Infect DisClin Infect Dis. 2018 May 17;66(11):1705-1711. doi: 10.1093/cid/cix1097.
Robinson ML, Kadam D, Kagal A, Khadse S, Kinikar A, Valvi C, Basavaraj A, Bharadwaj R, Marbaniang I, Kanade S, Raichur P, Sachs J, Klein E, Cosgrove S, Gupta A, Mave VAntibiotic Utilization and the Role of Suspected and Diagnosed Mosquito-borne Illness Among Adults and Children With Acute Febrile Illness in Pune, India2018-5-2Clin Infect DisClin Infect Dis. 2018 May 2;66(10):1602-1609. doi: 10.1093/cid/cix1059.
Richter SS, Karichu J, Otiso J, Van Heule H, Keller G, Cober E, Rojas LJ, Hujer AM, Hujer KM, Marshall S, Perez F, Rudin SD, Domitrovic TN, Kaye KS, Salata R, van Duin D, Bonomo RAEvaluation of Sensititre Broth Microdilution Plate for determining the susceptibility of carbapenem-resistant Klebsiella pneumoniae to polymyxins2018-5-1Diagn Microbiol Infect DisDiagn Microbiol Infect Dis. 2018 May;91(1):89-92.
Gopalsamy SN, Sherman A, Woodworth MH, Lutgring JD, Kraft CSFecal Microbiota Transplant for Multidrug-Resistant Organism Decolonization Administered During Septic Shock2018-4-1Infect Control Hosp EpidemiolInfect Control Hosp Epidemiol. 2018 Apr;39(4):490-492. doi: 10.1017/ice.2017.300. Epub 2018 Jan 18.
Kanwar A, Marshall SH, Perez F, Tomas M, Jacobs MR, Hujer AM, Domitrovic TN, Rudin SD, Rojas LJ, Kreiswirth BN, Chen L, Quinones-Mateu M, van Duin D, Bonomo RA; Antibacterial Resistance Leadership GroupEmergence of Resistance to Colistin During the Treatment of Bloodstream Infection Caused by Klebsiella pneumoniae Carbapenemase-Producing Klebsiella pneumoniae2018-4-1Open Forum Infect DisOpen Forum Infect Dis. 2018 Apr 23;5(4):ofy054. doi: 10.1093/ofid/ofy054. eCollection 2018 Apr.
Huskins WC, Fowler VG Jr, Evans SAdaptive Designs for Clinical Trials: Application to Healthcare Epidemiology Research2018-3-19Clin Infect DisClin Infect Dis. 2018 Mar 19;66(7):1140-1146. doi: 10.1093/cid/cix907.
Wang T, Kraft CS, Woodworth MH, Dhere T, Eaton MEFecal Microbiota Transplant for Refractory Clostridium difficile Infection Interrupts 25-Year History of Recurrent Urinary Tract Infections2018-2-1Open Forum Infect DisOpen Forum Infect Dis. 2018 Jan 15;5(2):ofy016. doi: 10.1093/ofid/ofy016. eCollection 2018 Feb.
Open Forum Infect Dis. 2018 Jan 15;5(2):ofy016. doi: 10.1093/ofid/ofy016. eCollection 2018 Feb.
El Chakhtoura NG, Saade E, Iovleva A, Yasmin M, Wilson B, Perez F, Bonomo RATherapies for multidrug resistant and extensively drug-resistant non-fermenting gram-negative bacteria causing nosocomial infections: a perilous journey toward 'molecularly targeted' therapy2018-2-1Expert Rev Anti Infect TherExpert Rev Anti Infect Ther. 2018 Feb;16(2):89-110. doi: 10.1080/14787210.2018.1425139. Epub 2018 Jan 16.
Hamasaki T, Evans SR, Asakura KDesign, data monitoring, and analysis of clinical trials with co-primary endpoints: A review2018-1-31J Biopharm StatJ Biopharm Stat. 2018;28(1):28-51. doi: 10.1080/10543406.2017.1378668. Epub 2017 Oct 30.
Tsalik EL, Bonomo RA, Fowler VGNew Molecular Diagnostic Approaches to Bacterial Infections and Antibacterial Resistance2018-1-29Annu Rev MedAnnu Rev Med. 2018 Jan 29;69:379-394. doi: 10.1146/annurev-med-052716-030320.
Springer J, White PL, Kessel J, Wieters I, Teschner D, Korczynski D, Liebregts T, Cornely OA, Schwartz S, Elgeti T, Meintker L, Krause SW, Posso RB, Heinz WJ, Fuhrmann S, Vehreschild JJ, Einsele H, Rickerts V, Loeffler JA Comparison of Aspergillus and Mucorales PCR Testing of Different Bronchoalveolar Lavage Fluid Fractions from Patients with Suspected Invasive Pulmonary Fungal Disease2018-1-24J Clin MicrobiolJ Clin Microbiol. 2018 Jan 24;56(2). pii: e01655-17. doi: 10.1128/JCM.01655-17
Van Duin D, Lok J, Earley M, Cober E, Richter S, Perez F, Salata R, Kalayjian R, Watkins R, Doi Y, Kaye K, Fowler V Jr, Paterson D, Bonomo R, Evans SColistin Versus Ceftazidime-Avibactam in the Treatment of Infections due to Carbapenem-Resistant Enterobacteriaceae2018-1-6Clin Infect DisClin Infect Dis. 2018 Jan 6;66(2):163-171. doi: 10.1093/cid/cix783.
Chotiprasitsakul D, Han JH, Cosgrove SE, Harris AD, Lautenbach E, Conley AT, Tolomeo P, Wise J, & Tamma PD for the Antibacterial Resistance Leadership GroupComparing the Outcomes of Adults with Enterobacteriaceae Bacteremia Receiving Short-Course versus Prolonged-Course Antibiotic Therapy in a Propensity-Score Matched Multicenter Cohort2018-1-6Clin Infect DisClin Infect Dis. 2018 Jan 6;66(2):172-177. doi: 10.1093/cid/cix767.
Eilertson B, Cober E, Richter SS, Perez F, Salata RA, Kalayjian RC, Watkins RR, Doi Y, Kaye KS, Evans S, Fowler VG, Bonomo RA, DeHovitz J, Kreiswirth B, van Duin D, for the ARLGCarbapenem-Resistant Enterobacteriaceae Infections in Patients on Renal Replacement Therapy2017-10-6Open Forum Infect DisOpen Forum Infect Dis. 2017 Oct 6;4(4):ofx216. doi: 10.1093/ofid/ofx216. eCollection 2017 Fall.
Nielsen TB, Pantapalangkoor P, Yan J, Luna BM, Dekitani K, Bruhn K, Tan B, Junus J, Bonomo RA, Schmidt AM, Everson M, Duncanson F, Doherty TM, Lin L, Spellberg BDiabetes Exacerbates Infection via Hyperinflammation by Signaling through TLR4 and RAGE2017-8-22mBioMBio. 2017 Aug 22;8(4). pii: e00818-17.
Henig O, Cober E, Richter SS, Perez F, Salata RA, Kalayjian RC, Watkins RR, Marshall S, Rudin SD, Domitrovic TN, Hujer AM, Hujer KM, Doi Y, Evans S, Fowler VG, Bonomo RA, van Duin D, Kaye KS, for the Antibacterial Resistance Leadership GroupA Prospective Observational Study of the Epidemiology, Management and Outcomes of Skin and Soft Tissue Infections due to Carbapenem-Resistant Enterobacteriaceae2017-7-27Open Forum Infect DisOpen Forum Infect Dis 2017;4(3):ofx157. https://doi.org/10.1093/ofid/ofx157
Fabre V, Cosgrove SE A Coordinated and Sustained Response to the Threat of Antibiotic Resistance Is Critical: Lessons Learned From Israel2017-7-18Clin Infect DisClin Infect Dis. 2017 Nov 29;65(12):2150-2152. doi: 10.1093/cid/cix619
Thom KA, Rock C, Jackson SS, Johnson JK, Srinivasan A, Magder LS, Roghmann MC, Bonomo RA, Harris ADFactors Leading to Transmission Risk of Acinetobacter baumannii2017-7-1Crit Care MedCrit Care Med. 2017 Jul;45(7):e633-e639. doi: 10.1097/CCM.0000000000002318.
Asakura K, Hamasaki T, Evans SRInterim evaluation of efficacy or futility in group-sequential trials with multiple co-primary endpoints2017-7-1Biom JBiom J. 2017 Jul;59(4):703-731. doi: 10.1002/bimj.201600026. Epub 2016 Oct 19.
Rojas LJ, Hujer AM, Rudin SD, Wright MS, Domitrovic TN, Marshall SH, Hujer KM, Richter SS, Cober E, Perez F, Adams MD, van Duin D, Bonomo RANDM-5 and OXA-181 Beta-Lactamases, a Significant Threat Continues To Spread in the Americas.2017-6-27Antimicrob Agents ChemotherAntimicrob Agents Chemother. 2017 Jun 27;61(7). pii: e00454-17. doi: 10.1128/AAC.00454-17. Print 2017 Jul.
Shin WS, Bergstrom A, Bonomo RA, Crowder MW, Muthyala R, Sham YYDiscovery of 1-Hydroxypyridine-2(1H)-thione-6-carboxylic Acid as aFirst-in-Class Low-Cytotoxic Nanomolar Metallo beta-Lactamase Inhibitor2017-6-7ChemMedChemChemMedChem. 2017 Jun 7;12(11):845-849. doi: 10.1002/cmdc.201700182. Epub 2017 May 22.
Evans SR, Hujer AM, Jiang H, Hill CB, Hujer KM, Mediavilla JR, Manca C, Tran TTT, Domitrovic TN, Higgins PG, Seifert H, Kreiswirth BN, Patel R, Jacobs MR, Chen L, Sampath R, Hall T, Marzan C, Fowler VG Jr, Chambers HF, Bonomo RACorrection for Evans et al., "Informing Antibiotic Treatment Decisions: Evaluating Rapid Molecular Diagnostics To Identify Susceptibility and Resistance to Carbapenems against Acinetobacter spp. in PRIMERS III"2017-6-1J Clin MicrobiolJ Clin Microbiol. 2017 Jun;55(6):1970. doi: 10.1128/JCM.00525-17.
Thaden JT, Park LP, Maskarinec SA, Ruffin F, Fowler VG, Van Duin DResults from a 13-Year Prospective Cohort Study Show Increased Mortality Associated with Bloodstream Infections Caused by Pseudomonas aeruginosa Compared to Other Bacteria2017-5-24Antimicrob Agents ChemotherAntimicrob Agents Chemother. 2017 May 24;61(6). pii: e02671-16.
Evans SR, Harris ADMethods and Issues in Studies of CRE2017-5-19VirulenceVirulence. 2017 May 19;8(4):453-459. doi: 10.1080/21505594.2016.1213473. Epub 2016 Jul 28.
Sugimoto T, Hamasaki T, Evans SR, Sozu TSizing clinical trials when comparing bivariate time-to-event outcomes2017-4-30Stat MedStat Med. 2017 Apr 30;36(9):1363-1382.
Ochiai T, Hamasaki T, Evans SR, Asakura K, Ohno YGroup-Sequential Three-Armnoninferiority Clinical Trial Designs2017-4-17J Biopharm StatJ Biopharm Stat. 2016 Feb 18:1-25.
Marshall S, Hujer AM, Rojas LJ, Papp-Wallace KM, Humphries RM, Spellberg B, Hujer KM, Marshall EK, Rudin SD, Perez F, Wilson BM, Wasserman RB, Chikowski L, Paterson DL, Vila AJ, van Duin D, Kreiswirth BN, Chambers HF, Fowler VG Jr, Jacobs MR, Pulse ME, Weiss WJ, Bonomo RACan Ceftazidime-Avibactam and Aztreonam Overcome Beta-Lactam Resistance Conferred by Metallo-beta-Lactamases in Enterobacteriaceae?2017-3-24Antimicrob Agents ChemotherAntimicrob Agents Chemother. 2017 Mar 24;61(4). pii: e02243-16.
Rojas LJ, Salim M, Cober E, Richter SS, Perez F, Salata RA, Kalayjian RC, Watkins RR, Marshall S, Rudin SD, Domitrovic TN, Hujer AM, Hujer KM, Doi Y, Kaye KS, Evans SE, Fowler VG, Bonomo RA, van Duin DColistin Resistance in Carbapenem-Resistant Klebsiella pneumoniae: Laboratory Detection and Impact on Mortality2017-3-15Clin Infect DisClin Infect Dis. 2017 Mar 15;64(6):711-718. doi: 10.1093/cid/ciw805.
Murray B, Jezek ACID Supplement: The Antibacterial Resistance Leadership Group: The First Steps2017-3-15Clin Infect DisClin Infect Dis. 2017 Mar 15;64(suppl_1):S1-S2. doi: 10.1093/cid/ciw823.
Chambers HF, Cross HR, Evans SR, Kreiswirth BN, Fowler VG, and the ARLGCID Supplement: The Antibacterial Resistance Leadership Group: Progress Report and Work in Progress2017-3-15Clin Infect DisClin Infect Dis. 2017 Mar 15;64(suppl_1):S3-S7. doi: 10.1093/cid/ciw824.
Cross HR, Harris A, Arias RK, Chambers HF, Fowler VG, and the LOC of the ARLGCID Supplement: Transforming Concepts into Clinical Trials and Creating a Multisite Network: The Leadership and Operations Center of the Antibacterial Resistance Leadership Group2017-3-15Clin Infect DisClin Infect Dis. 2017 Mar 15;64(suppl_1):S8-S12. doi: 10.1093/cid/ciw825.
Manca C, Hill C, Hujer AM, Patel R, Evans SR, Bonomo RA, Kreiswirth BN, and the LC of the ARLGCID Supplement: Leading Antibacterial Laboratory Research by Integrating Conventional and Innovative Approaches: The Laboratory Center of the Antibacterial Resistance Leadership Group2017-3-15Clin Infect DisClin Infect Dis. 2017 Mar 15;64(suppl_1):S13-S17. doi: 10.1093/cid/ciw826.
Huvane J, Komarow L, Hill C, Tran T, Pereira C, Rosenkranz SL, Finnemeyer M, Earley M, Jiang J, Wangt R, Lok J, Evans SR, and the SDMC of the ARLGCID Supplement: Fundamentals and Catalytic Innovation: The Statistical and Data Management Center of the Antibacterial Resistance Leadership Group2017-3-15Clin Infect DisClin Infect Dis. 2017 Mar 15;64(suppl_1):S18-S23. doi: 10.1093/cid/ciw827.
Doernberg SB, Lodise TP, Thaden JT, Munita J, Cosgrove S, Arias C, Boucher H, Corey GR, Lowy F, Murray B, Miller LG, Holland, and the Gram-Positive Committee of the ARLGCID Supplement: Gram-Positive Bacterial Infections: Research Priorities, Accomplishments, and Future Directions of the Antibacterial Resistance Leadership Group2017-3-15Clin Infect DisClin Infect Dis. 2017 Mar 15;64(suppl_1):S24-S29. doi: 10.1093/cid/ciw828.
Doi Y, Bonomo RA, Hooper DC, Kaye KS, Johnson JR, Clancy CJ, Thaden JT, Stryjewski ME, van Duin D, and the Gram-Negative Committee of the ARLGCID Supplement: Gram-Negative Bacterial Infections: Research Priorities, Accomplishments, and Future Directions of the Antibacterial Resistance Leadership Group2017-3-15Clin Infect DisClin Infect Dis. 2017 Mar 15;64(suppl_1):S30-S35. doi: 10.1093/cid/ciw829.
Anderson DJ, Jenkins T, Evans S, Harris A, Weinstein R, Tamma P, Han J, Banarjee R, Patel R, Zaoutis T, Lautenbach E, and the Stewardship and Infection Control Committee of the ARLGCID Supplement: The Role of Stewardship in Addressing Antibacterial Resistance: Stewardship and Infection Control Committee of the Antibacterial Resistance Leadership Group2017-3-15Clin Infect DisClin Infect Dis. 2017 Mar 15;64(suppl_1):S36-S40. doi: 10.1093/cid/ciw830.
Tsalik EL, Petzold E, Kreiswirth BN, Bonomo RA, Banerjee R, Lautenbach E, Evans SR, Hanson KE, Patel R, and the Diagnostics and Devices Committee of the ARLGCID Supplement: Advancing Diagnostics to Address Antibacterial Resistance: The Diagnostics and Devices Committee of the Antibacterial Resistance Leadership Group2017-3-15Clin Infect DisClin Infect Dis. 2017 Mar 15;64(suppl_1):S41-S47. doi: 10.1093/cid/ciw831.
Evans SR, Powers JEvaluating Anti-Infective Drugs in the Resistant Pathogen Setting: Can we Use External Controls?2017-3-14Stat Commun Infect DisStat Commun Infect Dis. 2017;9(1). pii: 20160003.
Haidar G, Clancy CJ, Shields RK, Hao B, Cheng S, Nguyen MHMutations in blaKPC-3 That Confer Ceftazidime-Avibactam Resistance Encode Novel KPC-3 Variants That Function as Extended-Spectrum ?-Lactamases2017-2-23Antimicrob Agents ChemotherAntimicrob Agents Chemother. 2017 Feb 23;61(3). pii: e02097-16.
Shields RK, Chen L, Cheng S, Chavda KD, Press EG, Snyder A, Pandey R, Doi Y, Kreiswirth BN, Nguyen MH, Clancy CJEmergence of Ceftazidime-Avibactam Resistance Due to Plasmid-Borne blaKPC-3 Mutations during Treatment of Carbapenem-Resistant Klebsiella pneumoniae Infections2017-2-23Antimicrob Agents ChemotherAntimicrob Agents Chemother. 2017 Feb 23;61(3). pii: e02097-16.
Patel R, Tsalik EL, Petzold E, Fowler VG, Klausner JD, Evans S, and the Antibaceterial Resistance Leadership GroupMASTERMIND – Bringing Microbial Diagnostics to the Clinic2017-2-1Clin Infect DisClin Infect Dis. 2017 Feb 1;64(3):355-360. doi: 10.1093/cid/ciw788. Epub 2016 Dec 7.
Viau RA, Kiedrowski LM, Kreiswirth BN, Adams M, Perez F, Marchaim D, Guerrero DM, Kaye KS, Logan LK, Villegas MV, Bonomo RAA Comparison of Molecular Typing Methods Applied to Enterobacter cloacae complex: hsp60 Sequencing, Rep-PCR, and MLST2017-2-1Pathog ImmunPathog Immun. 2017;2(1):23-33. doi: 10.20411/pai.v2i1.99. Epub 2017 Feb 1.
Wong D, Nielsen TB, Bonomo RA, Pantapalangkoor P, Luna B, Spellberg BClinical and Pathophysiological Overview of Acinetobacter Infections: a Century of Challenges2017-1-1Clin Microbiol RevClin Microbiol Rev. 2017 Jan;30(1):409-447.
Evans SR, Hujer AM, Jiang H, Hill CB, Hujer KM, Mediavilla JR, Manca C, Tran TT, Domitrovic TN, Higgins PG, Kreiswirth BN, Patel R, Jacobs MR, Chen L, Sampath R, Hall T, Marzan C, Fowler V, Chambers H, Bonomo RA, and the Antibacterial Resistance Leadership GroupInforming Antibiotic Treatment Decisions: Evaluating Rapid Molecular Diagnostics (RMDs) to Identify Susceptibility and Resistance to Carbapenems against Acinetobacter spp. PRIMERS III2016-12-28J Clin MicrobiolJ Clin Microbiol. 2016 Dec 28;55(1):134-144. doi: 10.1128/JCM.01524-16. Print 2017 Jan.
Spellberg B, Bonomo RAEditorial Commentary: Ceftazidime-Avibactam and Carbapenem-Resistant Enterobacteriaceae: ''We're Gonna Need a Bigger Boat''2016-12-15Clin Infect DisClin Infect Dis. 2016 Dec 15;63(12):1619-1621. Epub 2016 Sep 13.
Evans, SR, FollmannUsing Outcomes to Analyze Patients Rather than Patients to Analyze Outcomes: A Step Toward Pragmatism in Benefit:Risk Evaluation2016-12-6Stat Biopharm ResStat Biopharm Res 2016;8(4):386-393.
Pennello G, Pantoja-Galicia N, Evans SComparing diagnostic tests on benefit-risk2016-12-1J Biopharm StatJ Biopharm Stat. 2016;26(6):1083-1097. Epub 2016 Aug 22.
Banerjee R, Ozenci V, Patel RIndividualized Approaches Are Needed for Optimized Blood Cultures2016-11-15Clin Infect DisClin Infect Dis. 2016 Nov 15;63(10):1332-1339. Epub 2016 Aug 23.
Spellberg B, Bartlett JG, Gilbert DNHow to Pitch an Antibiotic Stewardship Program to the Hospital C-Suite2016-10-15Open Forum Infect DisOpen Forum Infect Dis. 2016 Oct 15;3(4):ofw210. eCollection 2016 Oct.
Patel RNew Developments in Clinical Bacteriology Laboratories2016-10-1Mayo Clin ProcMayo Clin Proc. 2016 Oct;91(10):1448-1459. doi: 10.1016/j.mayocp.2016.06.020. Epub 2016 Aug 21.
Goodman KE, Lessler J, Cosgrove SE, Harris AD, Lautenbach E, Han JH, Milstone AM, Massey CJ, Tamma PD; Antibacterial Resistance Leadership Group.A Clinical Decision Tree to Predict Whether a Bacteremic Patient Is Infected With an Extended-Spectrum ?-Lactamase-Producing Organism2016-10-1Clin Infect DisClin Infect Dis. 2016 Oct 1;63(7):896-903.
Mills JP, Wilck MB, Weikert BC, Porrett PM, Timko D, Alby K, Bonomo RA, Blumberg EASuccessful treatment of a disseminated infection with extensively drug-resistant Klebsiella pneumoniae in a liver transplant recipient with a fosfomycin-based multidrug regimen2016-10-1Transpl Infect DisTranspl Infect Dis. 2016 Oct;18(5):777-781.
Evans S, Pennello G, Pantoja-Galicia N, Jiang H, Hujer AM, Hujer KM, Manca C, Hill C, Jacobs MR, Chen L, Patel R, Kreiswirth BN, Bonomo RA, and the Antibacterial Resistance Leadership Group (ARLG)Benefit-Risk Evaluation for Diagnostics: a Framework (BED-FRAME)2016-9-15Clin Infect DisClin Infect Dis. 2016 Sep 15;63(6):812-7.
Spellberg BThe New Antibiotic Mantra-''Shorter Is Better''2016-9-1JAMA Intern MedJAMA Intern Med. 2016 Sep 1; 176(9): 1254–1255.
van Duin D, Bonomo RACeftazidime/Avibactam and Ceftolozane/Tazobactam: Second-generation Beta-Lactam/Beta-Lactamase Inhibitor Combinations2016-7-15Clin Infect DisClin Infect Dis. 2016 Jul 15;63(2):234-41.
Hauck C, Cober E, Richter SS, Perez F, Salata RA, Kalayjian RC, Watkins RR, Scalera NM, Doi Y, Kaye KS, Evans S, Fowler Jr VG, Bonomo RA, van Duin D, for the Antibacterial Resistance Leadership GroupSpectrum of Excess Mortality due to Carbapenem-Resistant Klebsiella pneumoniae Infections2016-6-30Clin Microbiol InfectClin Microbiol Infect. 2016 Jun;22(6):513-9.
Perez F, El Chakhtoura NG, Papp-Wallace KM, Wilson BM, Bonomo RATreatment options for infections caused by carbapenem-resistant Enterobacteriaceae: can we apply "precision medicine" to antimicrobial chemotherapy?2016-4-1Expert Opin PharmacotherExpert Opin Pharmacother. 2016 Apr;17(6):761-81.
Messina JA, Cober E, Richter SS, Perez F, Salata RA, Kalayjian RC, Watkins RR, Kaye KS, Evans S, Bonomo RA, Fowler Jr VG, van Duin DHospital Readmissions in Patients with Carbapenem-Resistant Klebsiella 1 pneumoniae2016-3-31Infect Control Hosp EpidemiolInfect Control Hosp Epidemiol. 2015 Dec 21:1-8. [Epub ahead of print]
Evans S, Follmann D, Schoenfeld D, Fowler VG Jr, Chambers HFReply to Phillips, Morris, and Walker2016-3-15Clin Infect DisClin Infect Dis. 2016 Mar 15;62(6):815-6.
Wright MS, Iovleva A, Jacobs MR, Bonomo RA, Adams MDGenome Dynamics of Multidrug-resistant Acinetobacter baumannii during Infection and Treatment2016-3-3Genome MedGenome Med. 2016 Mar 3;8(1):26. doi: 10.1186/s13073-016-0279-y.
Thaden JT, Keller AE, Shire NJ, Camara MM, Otterson L, Huband M, Guenther CM, Zhao W, Warrener P, Stover KC, Foslwer VG, DiGiandomenico APseudomonas aeruginosa Bacteremic Patients Exhibit Non-Protective Antibody Titers against Therapeutic Antibody Targets PcrV and Psl Exopolysaccharide2016-2-15J Infect DisJ Infect Dis. 2016 Feb 15;213(4):640-8
Tsalik EL, Henao R, Nichols M, Burke T, Ko ER, McClain MT, Hudson LL, Mazur A, Freeman DH, Veldman T, Langley RJ, Quackenbush EB, Glickman SW, Cairns CB, Jaehne AK, Rivers EP, Otero RM, Zaas AK, Kingsmore SF, Lucas J, Fowler VG, Carin L, Ginsburg GS, Woods CWHost Gene Expression Classifiers Diagnose Acute Respiratory Illness Etiology2016-1-20Sci Transl MedSci Transl Med. 2016 Jan 20;8(322):322ra11.
Evans S, Hujer AM, Jiang H, Hujer KM, Hall T, Marzan C, Jacobs MR, Sampath R, Ecker DJ, Manca C, Chavda K, Zhang P, Fernandez H, Chen L, Mediavilla J, Hill C, Perez F, Caliendo A, Fowler V, Chambers H, Kreiswirth B, Bonomo RA, and the Antimicrobial Resistance Leadership GroupRapid Molecular Diagnostics, Antibiotic Treatment Decisions, and Developing Approaches to Inform Empiric Therapy: PRIMERS I and II2016-1-15Clin Infect DisClin Infect Dis. 2016 Jan 15;62(2):181-9
Messina JA, Thaden JT, Sharma-Kuinkel BK, Fowler VGImpact of Bacterial and Human Genetic Variation on Staphylococcus aureus Infections2016-1-14PLoS PathogensPLoS Pathog. 2016 Jan 14;12(1):e1005330.
Evans SR, Follmann DFundamentals and Innovation in Antibiotic Trials2015-12-17Stat Biopharm ResStat Biopharm Res. 2015;7(4):331-336.
Spellberg B, Doi YThe Rise of Fluoroquinolone-Resistant Escherichia coli in the Community: Scarier Than We Thought2015-12-15J Infect DisJ Infect Dis. 2015 Dec 15;212(12):1853-5.
Ericson JE, Popoola VO, Smith PB, Benjamin DK, Fowler VG, Benjamin DK Jr, Clark RH, Milstone AMBurden of Invasive Staphylococcus aureus Infections in Hospitalized Infants2015-12-1JAMA PediatrJAMA Pediatr. 2015;169(12):1105-1111
Thaden JT, Ericson JE, Cross H, Bergin S, Messina JA, Fowler VG Jr, Benjamin DK Jr, Clark RH, Hornik CP, Smith PBSurvival Benefit of Empirical Therapy for Staphylococcus aureus Bloodstream Infections in Infants2015-10-30Pediatr Infect Dis JPediatr Infect Dis J. 2015 Nov;34(11):1175-9.
Banerjee R,Teng C, Cunningham S, Ihde S, Steckelberg J, Moriarty JP, Shah ND, Mandrekar J, Patel RRandomized Trial of Rapid Multiplex Polymerase Chain Reaction-Based Blood Culture Identification and Susceptibility Testing2015-10-1Clin Infect DisClin Infect Dis. 2015 Oct 1;61(7):1071-80. doi: 10.1093/cid/civ447. Epub 2015 Jul 20.
Choe H, Narayanan AS, Gandhi DA, Weinberg A, Marcus RE, Lee Z, Bonomo RA, Greenfield EMImmunomodulatory Peptide IDR-1018 Decreases Implant Infection and Preserves Osseointegration2015-9-30Clin Orthop Relat ResClin Orthop Relat Res. 2015 Sep;473(9):2898-907.
Khatri A, Naeger Murphy N, Wiest P, Osborn M, Garber K, Hecker M, Hurless K, Rudin SD, Jacobs MR, Kalayjian RC, Salata RA, van Duin D, Perez F, Bonomo RA, Paterson DL, Harris PNCommunity-Acquired Pyelonephritis in Pregnancy Caused by KPC-Producing Klebsiella pneumoniae2015-8-31Antimicrob Agents ChemotherAntimicrob Agents Chemother. 2015 Aug;59(8):4375-8. doi: 10.1128/AAC.00553-15.
Bergin SP, Thaden J, Ericson JE, Cross H, Messina J, Clark RH, Fowler V, Benjamin DK, Hornik CP, Smith PBNeonatal Escherichia coli Bloodstream Infections: Clinical Outcomes and Impact of Initial Antibiotic Therapy2015-8-31Pediatr Infect Dis JPediatr Infect Dis J. 2015;34(9):933-936.
Evans SR, Rubin D, Follman D, Penello G, Huskins WC, Powers J, Schoenfeld D, Chuang-Stein C, Fowler V, Lautenbach E, Chambers HFDesirability of Outcome Ranking (DOOR) and Response Adjusted for Days of Antibiotic Risk (RADAR)2015-8-26Clin Infect DisClin Infect Dis. 2015 Sep 1;61(5):800-6.
van Duin D, Cober E, Richter SS, Perez F, Kalayjian RC, Salata RA, Evans S, Fowler VG, Bonomo RA, Kaye KSResidence in Skilled Nursing Facilities is associated with Tigecycline Nonsusceptibility in Carbapenem-Resistant Klebsiella pneumoniae2015-8-26Infect Control Hosp EpidemiolInfect Control Hosp Epidemiol. 2015 Aug;36(8):942-8
Uno H, Wittes J, Fu H, Solomon SD, Claggett B, Tian L, Cai T, Pfeffer MA, Evans SR, Wei LJAlternatives to Hazard Ratios for Comparing the Efficacy or Safety of Therapies in Noninferiority Studies2015-7-21Ann Intern MedAnn Intern Med. 2015 Jul 21;163(2):127-34.
Ando Y, Hamasaki T, Evans SR, Asakura K, Sugimoto T, Sozu T, Ohno YSample size considerations in clinical trials when comparing two interventions using multiple co-primary binary relative risk contrasts2015-6-24Stat Biopharm ResStat Biopharm Res. 2015 Jun 24;7(2):81-94.
Messina JA, Fowler VG Jr, Corey GROritavancin for Acute Bacterial Skin and Skin Structure Infections2015-5-17Expert Opin PharmacotherExpert Opin Pharmacother. 2015 May;16(7):1091-8.
Tamma PD, Han JH, Rock C, Harris AD, Lautenbach E, Hsu AJ, Avdic E, Cosgrove SE; for the Antibacterial Resistance Leadership GroupCarbapenem Therapy is Associated with Improved Survival Compared With Piperacillin-Tazobactam for Patients With Extended-Spectrum ?-Lactamase Bacteremia2015-5-1Clin Infect DisClin Infect Dis. 2015 May 1;60(9):1319-25. doi: 10.1093/cid/civ003. Epub 2015 Jan 13.
Hamasaki T, Asakura K, Evans SR, Sugimoto T, Suzo TGroup-sequential Strategies in Clinical Trials with Multiple Co-primary Outcomes2015-4-14Stat Biopharm ResStat Biopharm Res. 2015;7(1):36-54.
van Duin D, Cober E, Richter SS, Perez F, Kalayjian RC, Salata RA, Evans S, Fowler VG, Kaye KS, Bonomo RAImpact of Therapy and Strain Type on Outcomes in Urinary Tract Infections Caused by Carbapenem-Resistant Klebsiella Pneumoniae2015-4-1J Antimicrob ChemotherJ Antimicrob Chemother. 2015 Apr;70(4):1203-11
Tugal D, Lynch M, Hujer AM, Rudin S, Perez F, Bonomo RAMulti-Drug-Resistant Klebsiella pneumoniae Pancreatitis: A New Challenge in a Serious Surgical Infection2015-4-1Surg Infect (Larchmt)Surg Infect (Larchmt). 2015 Apr;16(2):188-93.
Ericson JE, Thaden J, Cross H, Clark RH, Fowler V, Benjamin DK Jr, Cohen-Wolkowiez M, Hornik CP, Smith PBNo Survival Benefit with Empirical Vancomycin Therapy for Coagulase-negative Staphylococcal Bloodstream Infections in Infants2015-3-17Pediatr Infect Dis JPediatr Infect Dis J. 2015 Apr;34(4):371-5.
Spellberg B, Barlett J, Wunderink R, Gilbert DNNovel Approaches Are Needed to Develop Tomorrow’s Antibacterial Therapies2015-1-15Am J Respir Crit Care MedAm J Respir Crit Care Med. 2015 Jan 15;191(2):135-40.
Wright MS, Suzuki Y, Jones MB, Marshall SH, Rudin SD, van Duin D, Kaye K, Jacobs M, Bonomo RA, Adams MDGenomic and Transcriptomic Analyses of Colistin-Resistant Clinical Isolates of Klebsiella pneumoniae Reveal Independent Pathways of Resistance2015-1-1Antimicrob Agents ChemotherAntimicrob Agents Chemother. 2015 Jan;59(1):536-43. doi: 10.1128/AAC.04037-14. Epub 2014 Nov 10.
van Duin D, Cober E, Richter SS, Perez F, Cline M, Kaye KS, Kalayjian RC, Salata RA, Evans S, Fowler VG, Bonomo RATigecycline Therapy for Carbapenem-Resistant Klebsiella pneumoniae (CRKP) Bacteriuria Leads to Tigecycline Resistance2014-12-1Clin Microbiol InfectClin Microbiol Infect. 2014 Dec;20(12):O1117-20. doi: 10.1111/1469-0691.12714. Epub 2014 Dec 12.
Vazquez Melendez EL, Farrell JJ, Hujer AM, Lowery KS, Sampath R, Bonomo RACulture Negative Empyema in A Critically Ill Child: An Opportunity for Rapid Molecular Diagnostics2014-11-22BMC AnesthesiolBMC Anesthesiol. 2014 Nov 22;14:107. doi: 10.1186/1471-2253-14-107. eCollection 2014.
Perez F, Adachi J, Bonomo RAAntibiotic-Resistant Gram-Negative Bacterial Infections in Patients with Cancer2014-11-15Clin Infect DisClin Infect Dis. 2014 Nov 15;59 Suppl
5:S335-9. doi: 10.1093/cid/ciu612
Stafford KA, Boutin M, Evans SR, Harris ADDifficulties in Demonstrating Superiority of an Antibiotic for Multi-drug Resistant Bacteria in Non-Randomized Studies2014-10-15Clin Infect DisClin Infect Dis. 2014 Oct 15;59(8):1142-7. doi: 10.1093/cid/ciu486. Epub 2014 Jun 30.
Perez F, Hujer AM, Marshall SH, Ray AJ, Rather PN, Suwantarant N, Dumford D III, O’Shea P, Domitrovic TNJ, Salata RA, Chavda KD, Chen L, Kreiswirth BN, Vila AJ, Haussler SH, Jacobs MR, Bonomo RAExtensively Drug-Resistant Pseudomonas Aeruginosa Isolates Containing blaVIM-2 and Elements of Salmonella Genomic Island 2: A New Genetic Resistance Determinant in Northeast Ohio2014-10-1Antimicrob Agents ChemotherAntimicrob Agents
Chemother. 2014 Oct;58(10):5929-35. doi: 10.1128/AAC.02372-14. Epub 2014 Jul 28
Spellberg B, Gibert DNThe Future of Antibiotics and Resistance: A Tribute to a Career of Leadership by John Bartlett2014-9-15Clin Infect DisClin Infect Dis. 2014 Sep 15;59 Suppl 2:S71-5. doi: 10.1093/cid/ciu392.
David MZ, Daum RS, Bayer AS, Chambers HF, Fowler VG, Miller LG, Ostrowsky B, Baesa A, Boyle-Vavra S, Eells SJ, Garcia-Houchins S, Gialanella P, Macias-Gil R, Rude TH, Ruffin F, Sieth J, Volinski J, Spellberg BStaphylococcus aureus Bacteremia at Five U.S. Academic Medical Centers, 2008-2011: Significant Geographic Variation in Community-Onset Infections2014-9-15Clin Infect DisClin Infect Dis. 2014 Sep 15;59(6):798-807. doi: 10.1093/cid/ciu410. Epub 2014 May 30.
Holland TL, Arnold C, Fowler VG JrClinical Management of Staphylococcus aureus Bacteremia: A Review2014-9-1JAMAJAMA. 2014 Oct 1;312(13):1330-41. doi: 10.1001/jama.2014.9743.
Nagalingam S, Lisgaris M, Rodriguez B, Jacobs MR, Lederman M, Salata RA, Hujer AM, Muehlenbachs A, DeLeon-Carnes M, Farrell JJ, Sampath R, Bonomo RAIdentification of Occult Fusobacterium Nucleatum Central Nervous System Infection By Use of PCR-Electrospray Ionization Mass Spectrometry2014-9-1J Clin MicrobiolJ Clin Microbiol. 2014
Sep;52(9):3462-4. doi: 10.1128/JCM.01082-14. Epub 2014 Jun 25.
Wright MS, Perez F, Brinkac L, Jacobs MR, Kaye K, Cober E, van Duin D, Marshall SH, Hujer AM, Rudin SD, Hujer KM, Bonomo RA, Adams MDPopulation Structure of KPC-producing Klebsiella pneumoniae from Midwestern US hospitals2014-8-1Antimicrob Agents ChemotherAntimicrob Agents Chemother. 2014 Aug;58(8):4961-5. doi: 10.1128/AAC.00125-14. Epub 2014 Jun 9.
Asakura K, Hamasaki T, Sugimoto T, Hayashi K, Evans SR, Sozu TSample Size Determination in Group-Sequential Clinical Trials with Two Co-Primary Endpoints2014-7-1Stat MedStat Med. 2014 Jul 30;33(17):2897-913. doi: 10.1002/sim.6154. Epub 2014 Mar 27.
van Duin D, Perez F, Rudin SD, Cober E, Hanrahan J, Ziegler J, Webber R, Fox J, Mason P, Cline M, Hall G, Kaye K, Jacobs J, Kalayjian RC, Salata RA, Ramirez MS, Tolmalsky M, Evans S, Fowler VG Jr, Bonomo RASurveillance of Carbapenem-Resistant Klebsiella pneumoniae: Tracking Molecular Epidemiology and Outcomes through a Regional Network2014-7-1Antimicrob Agents ChemotherAntimicrob Agents Chemother. 2014 Jul;58(7):4035-41. doi: 10.1128/AAC.02636-14. Epub 2014 May 5.
Spellberg BThe Future of Antibiotics2014-6-27Crit CareCrit Care. 2014 Jun 27;18(3):228. doi: 10.1186/cc13948.
Ramirez MS, Xie G, Johnson S, Davenport K, van Duin D, Perez F, Bonomo RA, Chain P, Tolmasky MEGenome Sequences of Two Carbapenemase-Resistant Klebsiella pneumoniae ST258 Isolates2014-6-19Genome AnnouncGenome Announc. 2014 Jun 19;2(3). pii: e00558-14. doi: 10.1128/genomeA.00558-14.
Chambers HF, Bartlett JG, Bonomo RA, Chiou C, Cosgrove SE, Cross HR, Daum RS, Downing M, Evans SR, Knisely J, Kreiswirth BN, Lautenbach E, Mickley BS, Patel R, Pettigrew MM, Rodvold KA, Spellberg B, Fowler VG Jr.Antibacterial Resistance Leadership Group: Open for Business2014-6-1Clin Infect DisClin Infect Dis. 2014 Jun;58(11):1571-6. doi: 10.1093/cid/ciu132. Epub 2014 Mar 6.
Perez F, Bonomo RAVaccines for Acinetobacter baumannii: Thinking "Out of the Box"2014-5-7VaccineVaccine. 2014 May 7;32(22):2537-9.
Fowler VG Jr, Proctor RAWhere Does a Staphylococcus Aureus Vaccine Stand2014-5-1Clin Microbiol InfectClin Microbiol Infect. 2014 May;20 Suppl 5:66-75.
Spellberg BAntibiotic Judo: Working Gently with Prescriber Psychology to Overcome Inappropriate Use2014-3-31JAMA Intern MedJAMA Intern Med. 2014 Mar;174(3):432-3. doi: 10.1001/jamainternmed.2013.14019.
Perez F, Rudin SD, Marshall SH, Coakley P, Chen L, Kreiswirth BN, Rather PN, Hujer AM, Toltzis P, van Duin D, Paterson DL, Bonomo RAOqxAB, a quinolone and olaquindox efflux pump, is widely distributed among multidrug-resistant Klebsiella pneumoniae isolates of human origin2013-9-1Antimicrob Agents ChemotherAntimicrob Agents Chemother. 2013 Sep;57(9):4602-3.